MX2009001498A - Derivados de fenilo, piridina y quinolina. - Google Patents

Derivados de fenilo, piridina y quinolina.

Info

Publication number: MX2009001498A
Authority: MX; Mexico
Prior art keywords: piperidin; benzyl; chloro; ethoxy; amine
Prior art date: 2006-08-15

Application number

MX2009001498A

Other languages

English (en)

Spanish (es)

Inventor

Alfred Binggeli

Andreas D Christ

Hans P Maerki

Rainer E Martin

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-08-15

Filing date

2007-08-06

Publication date

2009-02-18

2007-08-06 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

2009-02-18 Publication of MX2009001498A publication Critical patent/MX2009001498A/es

Links

125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 title claims description 12
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 title description 34
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 title description 16
125000002943 quinolinyl group Chemical class N1=C(C=CC2=CC=CC=C12)* 0.000 title description 2
229940027991 antiseptic and disinfectant quinoline derivative Drugs 0.000 title 1
150000001875 compounds Chemical class 0.000 claims abstract description 397
238000000034 method Methods 0.000 claims abstract description 67
150000003839 salts Chemical class 0.000 claims abstract description 44
230000006806 disease prevention Effects 0.000 claims abstract description 10
230000008569 process Effects 0.000 claims abstract description 6
239000008194 pharmaceutical composition Substances 0.000 claims abstract description 5
-1 amino, pyrrolyl Chemical group 0.000 claims description 474
125000000217 alkyl group Chemical group 0.000 claims description 229
239000001257 hydrogen Substances 0.000 claims description 156
229910052739 hydrogen Inorganic materials 0.000 claims description 156
125000003545 alkoxy group Chemical group 0.000 claims description 92
229910052736 halogen Inorganic materials 0.000 claims description 91
150000002367 halogens Chemical class 0.000 claims description 90
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 72
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 60
125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 59
239000002253 acid Substances 0.000 claims description 37
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 32
206010012601 diabetes mellitus Diseases 0.000 claims description 31
125000004432 carbon atom Chemical group C* 0.000 claims description 25
125000001072 heteroaryl group Chemical group 0.000 claims description 23
208000001072 type 2 diabetes mellitus Diseases 0.000 claims description 19
125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 18
125000004093 cyano group Chemical group *C#N 0.000 claims description 17
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 17
125000000623 heterocyclic group Chemical group 0.000 claims description 17
239000011664 nicotinic acid Substances 0.000 claims description 16
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 14
239000008103 glucose Substances 0.000 claims description 14
125000004356 hydroxy functional group Chemical group O* 0.000 claims description 14
125000001188 haloalkyl group Chemical group 0.000 claims description 13
229960003512 nicotinic acid Drugs 0.000 claims description 13
125000004193 piperazinyl group Chemical group 0.000 claims description 11
125000003386 piperidinyl group Chemical group 0.000 claims description 11
125000000719 pyrrolidinyl group Chemical group 0.000 claims description 11
125000003831 tetrazolyl group Chemical group 0.000 claims description 11
125000003342 alkenyl group Chemical group 0.000 claims description 10
125000001589 carboacyl group Chemical group 0.000 claims description 10
208000035475 disorder Diseases 0.000 claims description 10
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 10
125000002757 morpholinyl group Chemical group 0.000 claims description 10
150000001299 aldehydes Chemical class 0.000 claims description 9
239000011737 fluorine Substances 0.000 claims description 9
229910052731 fluorine Inorganic materials 0.000 claims description 9
125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 claims description 8
QLRDXKWEIVIXFJ-UHFFFAOYSA-N 1-[(3-ethoxy-4-methoxyphenyl)methyl]piperidin-4-amine Chemical compound C1=C(OC)C(OCC)=CC(CN2CCC(N)CC2)=C1 QLRDXKWEIVIXFJ-UHFFFAOYSA-N 0.000 claims description 8
125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 8
239000003638 chemical reducing agent Substances 0.000 claims description 8
GZPHSAQLYPIAIN-UHFFFAOYSA-N 3-pyridinecarbonitrile Chemical compound N#CC1=CC=CN=C1 GZPHSAQLYPIAIN-UHFFFAOYSA-N 0.000 claims description 7
229910052799 carbon Inorganic materials 0.000 claims description 7
239000003814 drug Substances 0.000 claims description 7
JXZSBLCVWPTEEM-UHFFFAOYSA-N 2-[[1-[(3-ethoxy-4-methylphenyl)methyl]piperidin-4-yl]amino]pyridine-4-carbonitrile Chemical compound C1=C(C)C(OCC)=CC(CN2CCC(CC2)NC=2N=CC=C(C=2)C#N)=C1 JXZSBLCVWPTEEM-UHFFFAOYSA-N 0.000 claims description 6
GDQYVNLIQRRPCB-UHFFFAOYSA-N 2-[[1-[[3,5-di(propan-2-yloxy)phenyl]methyl]piperidin-4-yl]amino]pyridine-4-carbonitrile Chemical compound CC(C)OC1=CC(OC(C)C)=CC(CN2CCC(CC2)NC=2N=CC=C(C=2)C#N)=C1 GDQYVNLIQRRPCB-UHFFFAOYSA-N 0.000 claims description 6
CIQAEMQEXPZFLK-UHFFFAOYSA-N 2-chloro-6-[[1-[(4-chloro-3,5-diethoxyphenyl)methyl]piperidin-4-yl]amino]pyridine-4-carboxylic acid Chemical compound CCOC1=C(Cl)C(OCC)=CC(CN2CCC(CC2)NC=2N=C(Cl)C=C(C=2)C(O)=O)=C1 CIQAEMQEXPZFLK-UHFFFAOYSA-N 0.000 claims description 6
YNOKAJPQIGFYFZ-UHFFFAOYSA-N 6-[[1-[(3-ethoxy-4-methylphenyl)methyl]piperidin-4-yl]amino]pyridine-3-carbonitrile Chemical compound C1=C(C)C(OCC)=CC(CN2CCC(CC2)NC=2N=CC(=CC=2)C#N)=C1 YNOKAJPQIGFYFZ-UHFFFAOYSA-N 0.000 claims description 6
206010067584 Type 1 diabetes mellitus Diseases 0.000 claims description 6
238000004519 manufacturing process Methods 0.000 claims description 6
GWQWWVVRETUGNF-UHFFFAOYSA-N 2-[[1-[(3,5-diethoxy-4-fluorophenyl)methyl]piperidin-4-yl]amino]pyridine-4-carbonitrile Chemical compound CCOC1=C(F)C(OCC)=CC(CN2CCC(CC2)NC=2N=CC=C(C=2)C#N)=C1 GWQWWVVRETUGNF-UHFFFAOYSA-N 0.000 claims description 5
PYHHQPKEZBHOPA-UHFFFAOYSA-N 2-[[1-[(4-chloro-3-ethoxyphenyl)methyl]piperidin-4-yl]amino]pyridine-4-carbonitrile Chemical compound C1=C(Cl)C(OCC)=CC(CN2CCC(CC2)NC=2N=CC=C(C=2)C#N)=C1 PYHHQPKEZBHOPA-UHFFFAOYSA-N 0.000 claims description 5
125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims description 5
NMZRCUBHTBYESR-UHFFFAOYSA-N 6-[[1-[(4-chloro-3,5-diethoxyphenyl)methyl]piperidin-4-yl]amino]pyridine-3-carboxylic acid Chemical compound CCOC1=C(Cl)C(OCC)=CC(CN2CCC(CC2)NC=2N=CC(=CC=2)C(O)=O)=C1 NMZRCUBHTBYESR-UHFFFAOYSA-N 0.000 claims description 5
239000013543 active substance Substances 0.000 claims description 5
JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Substances N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 claims description 5
125000005113 hydroxyalkoxy group Chemical group 0.000 claims description 5
125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 5
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 5
125000000168 pyrrolyl group Chemical group 0.000 claims description 5
FKHHAJWBDXIJPT-UHFFFAOYSA-N 1-[(3-ethoxy-4-methoxyphenyl)methyl]-n-(4-ethylphenyl)piperidin-4-amine Chemical compound C1=C(OC)C(OCC)=CC(CN2CCC(CC2)NC=2C=CC(CC)=CC=2)=C1 FKHHAJWBDXIJPT-UHFFFAOYSA-N 0.000 claims description 4
XDFQSCBFEXSXHI-UHFFFAOYSA-N 1-[6-[[1-[(4-chloro-3,5-diethoxyphenyl)methyl]piperidin-4-yl]amino]pyridine-3-carbonyl]piperidine-4-carboxylic acid Chemical compound CCOC1=C(Cl)C(OCC)=CC(CN2CCC(CC2)NC=2N=CC(=CC=2)C(=O)N2CCC(CC2)C(O)=O)=C1 XDFQSCBFEXSXHI-UHFFFAOYSA-N 0.000 claims description 4
IUVYZYAMTOPPLM-UHFFFAOYSA-N 4-[[1-[(4-chloro-3-ethoxyphenyl)methyl]piperidin-4-yl]amino]benzonitrile Chemical compound C1=C(Cl)C(OCC)=CC(CN2CCC(CC2)NC=2C=CC(=CC=2)C#N)=C1 IUVYZYAMTOPPLM-UHFFFAOYSA-N 0.000 claims description 4
BWAIYLLHFFNRNR-UHFFFAOYSA-N 6-[[1-[(4-methoxy-3-propoxyphenyl)methyl]piperidin-4-yl]amino]-4-(trifluoromethyl)pyridine-3-carboxamide Chemical compound C1=C(OC)C(OCCC)=CC(CN2CCC(CC2)NC=2N=CC(=C(C=2)C(F)(F)F)C(N)=O)=C1 BWAIYLLHFFNRNR-UHFFFAOYSA-N 0.000 claims description 4
WRTGPRFPKKZPNS-UHFFFAOYSA-N 7-chloro-n-[1-[(3-ethoxy-4-methoxyphenyl)methyl]piperidin-4-yl]-4-(methoxymethyl)quinolin-2-amine Chemical compound C1=C(OC)C(OCC)=CC(CN2CCC(CC2)NC=2N=C3C=C(Cl)C=CC3=C(COC)C=2)=C1 WRTGPRFPKKZPNS-UHFFFAOYSA-N 0.000 claims description 4
208000002705 Glucose Intolerance Diseases 0.000 claims description 4
LERVPROEPVMZSU-UHFFFAOYSA-N [6-[[1-[(4-chloro-3,5-diethoxyphenyl)methyl]piperidin-4-yl]amino]pyridin-3-yl]-morpholin-4-ylmethanone Chemical compound CCOC1=C(Cl)C(OCC)=CC(CN2CCC(CC2)NC=2N=CC(=CC=2)C(=O)N2CCOCC2)=C1 LERVPROEPVMZSU-UHFFFAOYSA-N 0.000 claims description 4
125000003302 alkenyloxy group Chemical group 0.000 claims description 4
150000001408 amides Chemical class 0.000 claims description 4
125000004438 haloalkoxy group Chemical group 0.000 claims description 4
BPJHRSWUQSVDOU-UHFFFAOYSA-N n-[1-[(3-ethoxy-4-methoxyphenyl)methyl]piperidin-4-yl]-5-(trifluoromethyl)pyridin-2-amine Chemical compound C1=C(OC)C(OCC)=CC(CN2CCC(CC2)NC=2N=CC(=CC=2)C(F)(F)F)=C1 BPJHRSWUQSVDOU-UHFFFAOYSA-N 0.000 claims description 4
BWMVHGMDNVJTJV-UHFFFAOYSA-N n-[1-[(4-chloro-3,5-diethoxyphenyl)methyl]piperidin-4-yl]isoquinolin-1-amine Chemical compound CCOC1=C(Cl)C(OCC)=CC(CN2CCC(CC2)NC=2C3=CC=CC=C3C=CN=2)=C1 BWMVHGMDNVJTJV-UHFFFAOYSA-N 0.000 claims description 4
ZWDGOLWCVBFHIO-UHFFFAOYSA-N n-[1-[[3,5-di(propan-2-yloxy)phenyl]methyl]piperidin-4-yl]-5-(2h-tetrazol-5-yl)pyridin-2-amine Chemical compound CC(C)OC1=CC(OC(C)C)=CC(CN2CCC(CC2)NC=2N=CC(=CC=2)C=2NN=NN=2)=C1 ZWDGOLWCVBFHIO-UHFFFAOYSA-N 0.000 claims description 4
201000009104 prediabetes syndrome Diseases 0.000 claims description 4
230000002265 prevention Effects 0.000 claims description 4
NIPZZXUFJPQHNH-UHFFFAOYSA-M pyrazine-2-carboxylate Chemical compound [O-]C(=O)C1=CN=CC=N1 NIPZZXUFJPQHNH-UHFFFAOYSA-M 0.000 claims description 4
WMLMRQZBCSOZFR-UHFFFAOYSA-N 5-(1h-benzimidazol-2-yl)-n-[1-[(3-ethoxy-4-methoxyphenyl)methyl]piperidin-4-yl]pyridin-2-amine Chemical compound C1=C(OC)C(OCC)=CC(CN2CCC(CC2)NC=2N=CC(=CC=2)C=2NC3=CC=CC=C3N=2)=C1 WMLMRQZBCSOZFR-UHFFFAOYSA-N 0.000 claims description 3
XQPGQFZSRAHSBV-UHFFFAOYSA-N 6-[[1-[(3-ethoxy-4-methoxyphenyl)methyl]piperidin-4-yl]amino]pyridine-3-carbonitrile Chemical compound C1=C(OC)C(OCC)=CC(CN2CCC(CC2)NC=2N=CC(=CC=2)C#N)=C1 XQPGQFZSRAHSBV-UHFFFAOYSA-N 0.000 claims description 3
JQMZSXGDJGRPFU-UHFFFAOYSA-N 6-[[1-[(4-chloro-3-ethoxyphenyl)methyl]piperidin-4-yl]amino]-4-(trifluoromethyl)pyridine-3-carboxamide Chemical compound C1=C(Cl)C(OCC)=CC(CN2CCC(CC2)NC=2N=CC(=C(C=2)C(F)(F)F)C(N)=O)=C1 JQMZSXGDJGRPFU-UHFFFAOYSA-N 0.000 claims description 3
YVGMOEFRRHOCAT-UHFFFAOYSA-N 6-[[1-[(4-chloro-3-ethoxyphenyl)methyl]piperidin-4-yl]amino]pyridine-3-carboxylic acid Chemical compound C1=C(Cl)C(OCC)=CC(CN2CCC(CC2)NC=2N=CC(=CC=2)C(O)=O)=C1 YVGMOEFRRHOCAT-UHFFFAOYSA-N 0.000 claims description 3
LLDJQTVIRGBWIZ-UHFFFAOYSA-N 6-[[1-[(4-methoxy-3-propoxyphenyl)methyl]piperidin-4-yl]amino]-4-(trifluoromethyl)pyridine-3-carboxylic acid Chemical compound C1=C(OC)C(OCCC)=CC(CN2CCC(CC2)NC=2N=CC(=C(C=2)C(F)(F)F)C(O)=O)=C1 LLDJQTVIRGBWIZ-UHFFFAOYSA-N 0.000 claims description 3
GKMDMRCZBTXQAS-UHFFFAOYSA-N 6-[[1-[[4-methoxy-3-(2-methylpropoxy)phenyl]methyl]piperidin-4-yl]amino]-4-(trifluoromethyl)pyridine-3-carboxamide Chemical compound C1=C(OCC(C)C)C(OC)=CC=C1CN1CCC(NC=2N=CC(=C(C=2)C(F)(F)F)C(N)=O)CC1 GKMDMRCZBTXQAS-UHFFFAOYSA-N 0.000 claims description 3
IWGIXUHXCKYDCN-UHFFFAOYSA-N 6-chloro-n-[1-[(3-ethoxy-4-methoxyphenyl)methyl]piperidin-4-yl]pyridin-2-amine Chemical compound C1=C(OC)C(OCC)=CC(CN2CCC(CC2)NC=2N=C(Cl)C=CC=2)=C1 IWGIXUHXCKYDCN-UHFFFAOYSA-N 0.000 claims description 3
208000022559 Inflammatory bowel disease Diseases 0.000 claims description 3
206010025476 Malabsorption Diseases 0.000 claims description 3
208000004155 Malabsorption Syndromes Diseases 0.000 claims description 3
208000008589 Obesity Diseases 0.000 claims description 3
125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 3
125000005159 cyanoalkoxy group Chemical group 0.000 claims description 3
208000004104 gestational diabetes Diseases 0.000 claims description 3
125000005843 halogen group Chemical group 0.000 claims description 3
125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims description 3
VFQXVTODMYMSMJ-UHFFFAOYSA-N isonicotinamide Chemical compound NC(=O)C1=CC=NC=C1 VFQXVTODMYMSMJ-UHFFFAOYSA-N 0.000 claims description 3
VFDYFKXXJAVQFJ-UHFFFAOYSA-N methyl 5-[[1-[[3,5-diethoxy-4-(4-fluorophenyl)phenyl]methyl]piperidin-4-yl]amino]pyrazine-2-carboxylate Chemical compound C=1C(OCC)=C(C=2C=CC(F)=CC=2)C(OCC)=CC=1CN(CC1)CCC1NC1=CN=C(C(=O)OC)C=N1 VFDYFKXXJAVQFJ-UHFFFAOYSA-N 0.000 claims description 3
GDLCXLJDOXMORW-UHFFFAOYSA-N n-[1-[(3,5-diethoxy-4-fluorophenyl)methyl]piperidin-4-yl]-5-methylsulfonylpyridin-2-amine Chemical compound CCOC1=C(F)C(OCC)=CC(CN2CCC(CC2)NC=2N=CC(=CC=2)S(C)(=O)=O)=C1 GDLCXLJDOXMORW-UHFFFAOYSA-N 0.000 claims description 3
IESADDJGCBPYFG-UHFFFAOYSA-N n-[1-[(3-ethoxy-4-methoxyphenyl)methyl]piperidin-4-yl]quinolin-2-amine Chemical compound C1=C(OC)C(OCC)=CC(CN2CCC(CC2)NC=2N=C3C=CC=CC3=CC=2)=C1 IESADDJGCBPYFG-UHFFFAOYSA-N 0.000 claims description 3
IJYRTMDPOVBDQU-UHFFFAOYSA-N n-[1-[(4-chloro-3-ethoxyphenyl)methyl]piperidin-4-yl]quinolin-2-amine Chemical compound C1=C(Cl)C(OCC)=CC(CN2CCC(CC2)NC=2N=C3C=CC=CC3=CC=2)=C1 IJYRTMDPOVBDQU-UHFFFAOYSA-N 0.000 claims description 3
235000020824 obesity Nutrition 0.000 claims description 3
125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 3
AXZREWFVJWYBKI-UHFFFAOYSA-N 2-[6-[[1-[[3,5-diethoxy-4-(4-fluorophenyl)phenyl]methyl]piperidin-4-yl]amino]pyridin-3-yl]oxyacetonitrile Chemical compound C=1C(OCC)=C(C=2C=CC(F)=CC=2)C(OCC)=CC=1CN(CC1)CCC1NC1=CC=C(OCC#N)C=N1 AXZREWFVJWYBKI-UHFFFAOYSA-N 0.000 claims description 2
PERAEAAWGCNVIN-UHFFFAOYSA-N 2-[[1-[(3-ethoxy-4-methoxyphenyl)methyl]piperidin-4-yl]amino]-6-methyl-5-phenylpyridine-3-carbonitrile Chemical compound C1=C(OC)C(OCC)=CC(CN2CCC(CC2)NC=2C(=CC(=C(C)N=2)C=2C=CC=CC=2)C#N)=C1 PERAEAAWGCNVIN-UHFFFAOYSA-N 0.000 claims description 2
DZTZJHSMPMNJFW-UHFFFAOYSA-N 2-[[1-[(3-ethoxy-4-methylphenyl)methyl]piperidin-4-yl]amino]pyridine-4-carboxamide Chemical compound C1=C(C)C(OCC)=CC(CN2CCC(CC2)NC=2N=CC=C(C=2)C(N)=O)=C1 DZTZJHSMPMNJFW-UHFFFAOYSA-N 0.000 claims description 2
FPMLKNCTNMLHMU-UHFFFAOYSA-N 2-[[1-[(4-chloro-3-ethoxyphenyl)methyl]piperidin-4-yl]amino]-6-methylpyridine-3-carbonitrile Chemical compound C1=C(Cl)C(OCC)=CC(CN2CCC(CC2)NC=2C(=CC=C(C)N=2)C#N)=C1 FPMLKNCTNMLHMU-UHFFFAOYSA-N 0.000 claims description 2
125000004777 2-fluoroethyl group Chemical group [H]C([H])(F)C([H])([H])* 0.000 claims description 2
HVUGZUSNZYOUPN-UHFFFAOYSA-N 3-[[4-(isoquinolin-1-ylamino)piperidin-1-yl]methyl]-5-propan-2-yloxyphenol Chemical compound CC(C)OC1=CC(O)=CC(CN2CCC(CC2)NC=2C3=CC=CC=C3C=CN=2)=C1 HVUGZUSNZYOUPN-UHFFFAOYSA-N 0.000 claims description 2
CIFBQKLAPWPZCJ-UHFFFAOYSA-N 3-[[4-[(4-methylquinolin-2-yl)amino]piperidin-1-yl]methyl]-5-propan-2-yloxyphenol Chemical compound CC(C)OC1=CC(O)=CC(CN2CCC(CC2)NC=2N=C3C=CC=CC3=C(C)C=2)=C1 CIFBQKLAPWPZCJ-UHFFFAOYSA-N 0.000 claims description 2
UCAZFYUFYINLAX-UHFFFAOYSA-N 3-chloro-n-[1-[(3,5-diethoxyphenyl)methyl]piperidin-4-yl]isoquinolin-1-amine Chemical compound CCOC1=CC(OCC)=CC(CN2CCC(CC2)NC=2C3=CC=CC=C3C=C(Cl)N=2)=C1 UCAZFYUFYINLAX-UHFFFAOYSA-N 0.000 claims description 2
RZILZPHKIWTTMR-UHFFFAOYSA-N 3-chloro-n-[1-[(3-ethoxy-4-fluorophenyl)methyl]piperidin-4-yl]isoquinolin-1-amine Chemical compound C1=C(F)C(OCC)=CC(CN2CCC(CC2)NC=2C3=CC=CC=C3C=C(Cl)N=2)=C1 RZILZPHKIWTTMR-UHFFFAOYSA-N 0.000 claims description 2
ICOCSRDHKCFYBO-UHFFFAOYSA-N 3-chloro-n-[1-[(3-ethoxy-4-methoxyphenyl)methyl]piperidin-4-yl]isoquinolin-1-amine Chemical compound C1=C(OC)C(OCC)=CC(CN2CCC(CC2)NC=2C3=CC=CC=C3C=C(Cl)N=2)=C1 ICOCSRDHKCFYBO-UHFFFAOYSA-N 0.000 claims description 2
YECYOUPICOLECG-UHFFFAOYSA-N 3-chloro-n-[1-[(3-ethoxy-4-propan-2-yloxyphenyl)methyl]piperidin-4-yl]isoquinolin-1-amine Chemical compound C1=C(OC(C)C)C(OCC)=CC(CN2CCC(CC2)NC=2C3=CC=CC=C3C=C(Cl)N=2)=C1 YECYOUPICOLECG-UHFFFAOYSA-N 0.000 claims description 2
UINLODQOJQIKGY-UHFFFAOYSA-N 3-chloro-n-[1-[[3-ethoxy-4-(2-methylpropoxy)phenyl]methyl]piperidin-4-yl]isoquinolin-1-amine Chemical compound C1=C(OCC(C)C)C(OCC)=CC(CN2CCC(CC2)NC=2C3=CC=CC=C3C=C(Cl)N=2)=C1 UINLODQOJQIKGY-UHFFFAOYSA-N 0.000 claims description 2
UWLKRQCZCZXHAP-UHFFFAOYSA-N 3-chloro-n-[1-[[4-(difluoromethoxy)-3-ethoxyphenyl]methyl]piperidin-4-yl]isoquinolin-1-amine Chemical compound C1=C(OC(F)F)C(OCC)=CC(CN2CCC(CC2)NC=2C3=CC=CC=C3C=C(Cl)N=2)=C1 UWLKRQCZCZXHAP-UHFFFAOYSA-N 0.000 claims description 2
IBRLHEXWIYQXME-UHFFFAOYSA-N 3-chloro-n-[1-[[4-methoxy-3-(2-methylpropoxy)phenyl]methyl]piperidin-4-yl]isoquinolin-1-amine Chemical compound C1=C(OCC(C)C)C(OC)=CC=C1CN1CCC(NC=2C3=CC=CC=C3C=C(Cl)N=2)CC1 IBRLHEXWIYQXME-UHFFFAOYSA-N 0.000 claims description 2
BPJDSSXCHHMIDW-UHFFFAOYSA-N 4-[[1-[(3-ethoxy-4-methoxyphenyl)methyl]piperidin-4-yl]amino]-n-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide Chemical compound C1=C(OC)C(OCC)=CC(CN2CCC(CC2)NC=2C=CC(=CC=2)S(=O)(=O)NC2=NOC(C)=C2)=C1 BPJDSSXCHHMIDW-UHFFFAOYSA-N 0.000 claims description 2
GBIPHIUONILDHZ-UHFFFAOYSA-N 4-[[4-[(3-chloroisoquinolin-1-yl)amino]piperidin-1-yl]methyl]-2-ethoxyphenol Chemical compound C1=C(O)C(OCC)=CC(CN2CCC(CC2)NC=2C3=CC=CC=C3C=C(Cl)N=2)=C1 GBIPHIUONILDHZ-UHFFFAOYSA-N 0.000 claims description 2
HAVIEZATAQJRTK-UHFFFAOYSA-N 4-chloro-n-[1-[(4-chloro-3,5-diethoxyphenyl)methyl]piperidin-4-yl]quinolin-2-amine Chemical compound CCOC1=C(Cl)C(OCC)=CC(CN2CCC(CC2)NC=2N=C3C=CC=CC3=C(Cl)C=2)=C1 HAVIEZATAQJRTK-UHFFFAOYSA-N 0.000 claims description 2
UCRJTHUXPNIFBR-UHFFFAOYSA-N 6-[[1-[(3,5-diethoxy-4-fluorophenyl)methyl]piperidin-4-yl]amino]-4-(trifluoromethyl)pyridine-3-carboxamide Chemical compound CCOC1=C(F)C(OCC)=CC(CN2CCC(CC2)NC=2N=CC(=C(C=2)C(F)(F)F)C(N)=O)=C1 UCRJTHUXPNIFBR-UHFFFAOYSA-N 0.000 claims description 2
DIZMGHLOBQYOJB-UHFFFAOYSA-N 6-[[1-[(3-ethoxy-4-hydroxyphenyl)methyl]piperidin-4-yl]amino]pyridine-3-carboxylic acid Chemical compound C1=C(O)C(OCC)=CC(CN2CCC(CC2)NC=2N=CC(=CC=2)C(O)=O)=C1 DIZMGHLOBQYOJB-UHFFFAOYSA-N 0.000 claims description 2
MESWAAJNGXZZLT-UHFFFAOYSA-N 6-[[1-[(3-ethoxy-4-methoxyphenyl)methyl]piperidin-4-yl]amino]-4-(trifluoromethyl)pyridine-3-carboxylic acid Chemical compound C1=C(OC)C(OCC)=CC(CN2CCC(CC2)NC=2N=CC(=C(C=2)C(F)(F)F)C(O)=O)=C1 MESWAAJNGXZZLT-UHFFFAOYSA-N 0.000 claims description 2
GRFDIGJYEWELLR-UHFFFAOYSA-N 6-[[1-[(3-ethoxy-4-methylphenyl)methyl]piperidin-4-yl]amino]pyridine-3-carboxylic acid Chemical compound C1=C(C)C(OCC)=CC(CN2CCC(CC2)NC=2N=CC(=CC=2)C(O)=O)=C1 GRFDIGJYEWELLR-UHFFFAOYSA-N 0.000 claims description 2
UXOFBGXCXIZUQL-UHFFFAOYSA-N 6-[[1-[(4-chloro-3,5-diethoxyphenyl)methyl]piperidin-4-yl]amino]-n-(1,3-dihydroxypropan-2-yl)pyridine-3-carboxamide Chemical compound CCOC1=C(Cl)C(OCC)=CC(CN2CCC(CC2)NC=2N=CC(=CC=2)C(=O)NC(CO)CO)=C1 UXOFBGXCXIZUQL-UHFFFAOYSA-N 0.000 claims description 2
RLYZVLRHKHOTOI-UHFFFAOYSA-N 6-[[1-[(4-chloro-3,5-diethoxyphenyl)methyl]piperidin-4-yl]amino]-n-(2-hydroxyethyl)pyridine-3-carboxamide Chemical compound CCOC1=C(Cl)C(OCC)=CC(CN2CCC(CC2)NC=2N=CC(=CC=2)C(=O)NCCO)=C1 RLYZVLRHKHOTOI-UHFFFAOYSA-N 0.000 claims description 2
HIXGNJOIMSRTHP-UHFFFAOYSA-N 6-[[1-[(4-chloro-3,5-diethoxyphenyl)methyl]piperidin-4-yl]amino]-n-(2-methoxyethyl)pyridine-3-carboxamide Chemical compound CCOC1=C(Cl)C(OCC)=CC(CN2CCC(CC2)NC=2N=CC(=CC=2)C(=O)NCCOC)=C1 HIXGNJOIMSRTHP-UHFFFAOYSA-N 0.000 claims description 2
UZGNPAUXHBHFAO-UHFFFAOYSA-N 6-[[1-[(4-chloro-3,5-diethoxyphenyl)methyl]piperidin-4-yl]amino]-n-cyclobutylpyridine-3-carboxamide Chemical compound CCOC1=C(Cl)C(OCC)=CC(CN2CCC(CC2)NC=2N=CC(=CC=2)C(=O)NC2CCC2)=C1 UZGNPAUXHBHFAO-UHFFFAOYSA-N 0.000 claims description 2
GPSGRVSWKNQDBO-UHFFFAOYSA-N 6-[[1-[[3,5-di(propan-2-yloxy)phenyl]methyl]piperidin-4-yl]amino]pyridine-3-carboxylic acid Chemical compound CC(C)OC1=CC(OC(C)C)=CC(CN2CCC(CC2)NC=2N=CC(=CC=2)C(O)=O)=C1 GPSGRVSWKNQDBO-UHFFFAOYSA-N 0.000 claims description 2
PEKCGSWVSKCTEK-UHFFFAOYSA-N 6-chloro-n-[1-[(4-chloro-3-ethoxyphenyl)methyl]piperidin-4-yl]-4-(methoxymethyl)pyridin-2-amine Chemical compound C1=C(Cl)C(OCC)=CC(CN2CCC(CC2)NC=2N=C(Cl)C=C(COC)C=2)=C1 PEKCGSWVSKCTEK-UHFFFAOYSA-N 0.000 claims description 2
WBIYPVFGJSGQPS-UHFFFAOYSA-N 6-n-[1-[(4-chloro-3-ethoxyphenyl)methyl]piperidin-4-yl]-3-nitropyridine-2,6-diamine Chemical compound C1=C(Cl)C(OCC)=CC(CN2CCC(CC2)NC=2N=C(N)C(=CC=2)[N+]([O-])=O)=C1 WBIYPVFGJSGQPS-UHFFFAOYSA-N 0.000 claims description 2
OBNMRWJJDCDEJA-UHFFFAOYSA-N 8-chloro-n-[1-[(3,5-diethoxy-4-fluorophenyl)methyl]piperidin-4-yl]quinolin-2-amine Chemical compound CCOC1=C(F)C(OCC)=CC(CN2CCC(CC2)NC=2N=C3C(Cl)=CC=CC3=CC=2)=C1 OBNMRWJJDCDEJA-UHFFFAOYSA-N 0.000 claims description 2
BJVZOEAGBXHLAO-UHFFFAOYSA-N 8-chloro-n-[1-[(3,5-diethoxy-4-pyrrol-1-ylphenyl)methyl]piperidin-4-yl]quinolin-2-amine Chemical compound CCOC1=CC(CN2CCC(CC2)NC=2N=C3C(Cl)=CC=CC3=CC=2)=CC(OCC)=C1N1C=CC=C1 BJVZOEAGBXHLAO-UHFFFAOYSA-N 0.000 claims description 2
VQILOXNKULZZOP-UHFFFAOYSA-N 8-chloro-n-[1-[(3-ethoxy-4-methoxyphenyl)methyl]piperidin-4-yl]quinolin-2-amine Chemical compound C1=C(OC)C(OCC)=CC(CN2CCC(CC2)NC=2N=C3C(Cl)=CC=CC3=CC=2)=C1 VQILOXNKULZZOP-UHFFFAOYSA-N 0.000 claims description 2
XBAXGADCSNUETD-UHFFFAOYSA-N 8-chloro-n-[1-[(3-ethoxy-4-methylphenyl)methyl]piperidin-4-yl]quinolin-2-amine Chemical compound C1=C(C)C(OCC)=CC(CN2CCC(CC2)NC=2N=C3C(Cl)=CC=CC3=CC=2)=C1 XBAXGADCSNUETD-UHFFFAOYSA-N 0.000 claims description 2
ZQZOPZCVZPMYNL-UHFFFAOYSA-N 8-chloro-n-[1-[(4-chloro-3-ethoxyphenyl)methyl]piperidin-4-yl]quinolin-2-amine Chemical compound C1=C(Cl)C(OCC)=CC(CN2CCC(CC2)NC=2N=C3C(Cl)=CC=CC3=CC=2)=C1 ZQZOPZCVZPMYNL-UHFFFAOYSA-N 0.000 claims description 2
SAEBPJMODMXTHK-UHFFFAOYSA-N 8-chloro-n-[1-[(4-methoxy-3-propoxyphenyl)methyl]piperidin-4-yl]quinolin-2-amine Chemical compound C1=C(OC)C(OCCC)=CC(CN2CCC(CC2)NC=2N=C3C(Cl)=CC=CC3=CC=2)=C1 SAEBPJMODMXTHK-UHFFFAOYSA-N 0.000 claims description 2
DADPQOBJEKHBEX-UHFFFAOYSA-N 8-chloro-n-[1-[(8-ethoxy-2,2-dimethylchromen-6-yl)methyl]piperidin-4-yl]quinolin-2-amine Chemical compound C1=CC(C)(C)OC2=C1C=C(CN1CCC(CC1)NC=1N=C3C(Cl)=CC=CC3=CC=1)C=C2OCC DADPQOBJEKHBEX-UHFFFAOYSA-N 0.000 claims description 2
KIPZYGNTJLCPNW-UHFFFAOYSA-N 8-chloro-n-[1-[[4-methoxy-3-(2-methylpropoxy)phenyl]methyl]piperidin-4-yl]quinolin-2-amine Chemical compound C1=C(OCC(C)C)C(OC)=CC=C1CN1CCC(NC=2N=C3C(Cl)=CC=CC3=CC=2)CC1 KIPZYGNTJLCPNW-UHFFFAOYSA-N 0.000 claims description 2
208000023275 Autoimmune disease Diseases 0.000 claims description 2
ATHMZAGBSATVIR-UHFFFAOYSA-N CCOc1cc(CN2CCC(N)CC2)ccc1OC(CC)CC Chemical compound CCOc1cc(CN2CCC(N)CC2)ccc1OC(CC)CC ATHMZAGBSATVIR-UHFFFAOYSA-N 0.000 claims description 2
206010009900 Colitis ulcerative Diseases 0.000 claims description 2
208000011231 Crohn disease Diseases 0.000 claims description 2
206010061598 Immunodeficiency Diseases 0.000 claims description 2
208000029462 Immunodeficiency disease Diseases 0.000 claims description 2
201000004681 Psoriasis Diseases 0.000 claims description 2
201000006704 Ulcerative Colitis Diseases 0.000 claims description 2
PHDTUXCYYKXBGS-OAQYLSRUSA-N [6-[[1-[(4-chloro-3,5-diethoxyphenyl)methyl]piperidin-4-yl]amino]pyridin-3-yl]-[(3r)-3-hydroxypyrrolidin-1-yl]methanone Chemical compound CCOC1=C(Cl)C(OCC)=CC(CN2CCC(CC2)NC=2N=CC(=CC=2)C(=O)N2C[C@H](O)CC2)=C1 PHDTUXCYYKXBGS-OAQYLSRUSA-N 0.000 claims description 2
239000002671 adjuvant Substances 0.000 claims description 2
125000004181 carboxyalkyl group Chemical group 0.000 claims description 2
239000003937 drug carrier Substances 0.000 claims description 2
230000007813 immunodeficiency Effects 0.000 claims description 2
VINLRBVFAMICKV-UHFFFAOYSA-N n-[1-[(3,5-diethoxy-4-fluorophenyl)methyl]piperidin-4-yl]-4-methylquinolin-2-amine Chemical compound CCOC1=C(F)C(OCC)=CC(CN2CCC(CC2)NC=2N=C3C=CC=CC3=C(C)C=2)=C1 VINLRBVFAMICKV-UHFFFAOYSA-N 0.000 claims description 2
BMTKPBKJFHEICF-UHFFFAOYSA-N n-[1-[(3,5-diethoxy-4-fluorophenyl)methyl]piperidin-4-yl]quinolin-2-amine Chemical compound CCOC1=C(F)C(OCC)=CC(CN2CCC(CC2)NC=2N=C3C=CC=CC3=CC=2)=C1 BMTKPBKJFHEICF-UHFFFAOYSA-N 0.000 claims description 2
HBJRWUDFGCCIEB-UHFFFAOYSA-N n-[1-[(3,5-diethoxy-4-pyrrol-1-ylphenyl)methyl]piperidin-4-yl]-4-methylquinolin-2-amine Chemical compound CCOC1=CC(CN2CCC(CC2)NC=2N=C3C=CC=CC3=C(C)C=2)=CC(OCC)=C1N1C=CC=C1 HBJRWUDFGCCIEB-UHFFFAOYSA-N 0.000 claims description 2
HZFISUCDYZBQCH-UHFFFAOYSA-N n-[1-[(3,5-diethoxy-4-pyrrol-1-ylphenyl)methyl]piperidin-4-yl]isoquinolin-1-amine Chemical compound CCOC1=CC(CN2CCC(CC2)NC=2C3=CC=CC=C3C=CN=2)=CC(OCC)=C1N1C=CC=C1 HZFISUCDYZBQCH-UHFFFAOYSA-N 0.000 claims description 2
ZFYMZVKBRVQPRM-UHFFFAOYSA-N n-[1-[(3,5-diethoxy-4-pyrrol-1-ylphenyl)methyl]piperidin-4-yl]quinolin-2-amine Chemical compound CCOC1=CC(CN2CCC(CC2)NC=2N=C3C=CC=CC3=CC=2)=CC(OCC)=C1N1C=CC=C1 ZFYMZVKBRVQPRM-UHFFFAOYSA-N 0.000 claims description 2
CHORSNLSEXVIEH-UHFFFAOYSA-N n-[1-[(3,5-diethoxyphenyl)methyl]piperidin-4-yl]-5-(trifluoromethyl)pyridin-2-amine Chemical compound CCOC1=CC(OCC)=CC(CN2CCC(CC2)NC=2N=CC(=CC=2)C(F)(F)F)=C1 CHORSNLSEXVIEH-UHFFFAOYSA-N 0.000 claims description 2
QYGIDFCTBKXKLH-UHFFFAOYSA-N n-[1-[(3-butoxy-4-methoxyphenyl)methyl]piperidin-4-yl]-8-chloroquinolin-2-amine Chemical compound C1=C(OC)C(OCCCC)=CC(CN2CCC(CC2)NC=2N=C3C(Cl)=CC=CC3=CC=2)=C1 QYGIDFCTBKXKLH-UHFFFAOYSA-N 0.000 claims description 2
IWLHXNLQXQCANF-UHFFFAOYSA-N n-[1-[(3-butoxy-4-methoxyphenyl)methyl]piperidin-4-yl]isoquinolin-1-amine Chemical compound C1=C(OC)C(OCCCC)=CC(CN2CCC(CC2)NC=2C3=CC=CC=C3C=CN=2)=C1 IWLHXNLQXQCANF-UHFFFAOYSA-N 0.000 claims description 2
NYQKQSQULYAUNN-UHFFFAOYSA-N n-[1-[(3-ethoxy-4-fluorophenyl)methyl]piperidin-4-yl]-4-methylquinolin-2-amine Chemical compound C1=C(F)C(OCC)=CC(CN2CCC(CC2)NC=2N=C3C=CC=CC3=C(C)C=2)=C1 NYQKQSQULYAUNN-UHFFFAOYSA-N 0.000 claims description 2
GSAQFOCPNNSJQD-UHFFFAOYSA-N n-[1-[(3-ethoxy-4-fluorophenyl)methyl]piperidin-4-yl]quinolin-2-amine Chemical compound C1=C(F)C(OCC)=CC(CN2CCC(CC2)NC=2N=C3C=CC=CC3=CC=2)=C1 GSAQFOCPNNSJQD-UHFFFAOYSA-N 0.000 claims description 2
SSUCBIYJYMBCGG-UHFFFAOYSA-N n-[1-[(3-ethoxy-4-methoxyphenyl)methyl]piperidin-4-yl]-4-methylquinolin-2-amine Chemical compound C1=C(OC)C(OCC)=CC(CN2CCC(CC2)NC=2N=C3C=CC=CC3=C(C)C=2)=C1 SSUCBIYJYMBCGG-UHFFFAOYSA-N 0.000 claims description 2
AWIKIJBHVDISLW-UHFFFAOYSA-N n-[1-[(3-ethoxy-4-methoxyphenyl)methyl]piperidin-4-yl]-5-methyl-1,6-naphthyridin-2-amine Chemical compound C1=C(OC)C(OCC)=CC(CN2CCC(CC2)NC=2N=C3C=CN=C(C)C3=CC=2)=C1 AWIKIJBHVDISLW-UHFFFAOYSA-N 0.000 claims description 2
IBVTWLGJESJSAL-UHFFFAOYSA-N n-[1-[(3-ethoxy-4-methoxyphenyl)methyl]piperidin-4-yl]-5-nitropyridin-2-amine Chemical compound C1=C(OC)C(OCC)=CC(CN2CCC(CC2)NC=2N=CC(=CC=2)[N+]([O-])=O)=C1 IBVTWLGJESJSAL-UHFFFAOYSA-N 0.000 claims description 2
LGKKJGTUILNXNA-UHFFFAOYSA-N n-[1-[(3-ethoxy-4-methoxyphenyl)methyl]piperidin-4-yl]-6-methyl-5-nitropyridin-2-amine Chemical compound C1=C(OC)C(OCC)=CC(CN2CCC(CC2)NC=2N=C(C)C(=CC=2)[N+]([O-])=O)=C1 LGKKJGTUILNXNA-UHFFFAOYSA-N 0.000 claims description 2
JHRMYGSSWLWCLG-UHFFFAOYSA-N n-[1-[(3-ethoxy-4-methoxyphenyl)methyl]piperidin-4-yl]isoquinolin-1-amine Chemical compound C1=C(OC)C(OCC)=CC(CN2CCC(CC2)NC=2C3=CC=CC=C3C=CN=2)=C1 JHRMYGSSWLWCLG-UHFFFAOYSA-N 0.000 claims description 2
CJBVYWFCWFCJRP-UHFFFAOYSA-N n-[1-[(3-ethoxy-4-methylphenyl)methyl]piperidin-4-yl]-4-methylquinolin-2-amine Chemical compound C1=C(C)C(OCC)=CC(CN2CCC(CC2)NC=2N=C3C=CC=CC3=C(C)C=2)=C1 CJBVYWFCWFCJRP-UHFFFAOYSA-N 0.000 claims description 2
ZFKNQVAQCMTZEL-UHFFFAOYSA-N n-[1-[(3-ethoxy-4-pentan-3-yloxyphenyl)methyl]piperidin-4-yl]quinolin-2-amine Chemical compound C1=C(OC(CC)CC)C(OCC)=CC(CN2CCC(CC2)NC=2N=C3C=CC=CC3=CC=2)=C1 ZFKNQVAQCMTZEL-UHFFFAOYSA-N 0.000 claims description 2
KUTQDQOKIMDXDF-UHFFFAOYSA-N n-[1-[(4-amino-3,5-diethoxyphenyl)methyl]piperidin-4-yl]-4-methylquinolin-2-amine Chemical compound CCOC1=C(N)C(OCC)=CC(CN2CCC(CC2)NC=2N=C3C=CC=CC3=C(C)C=2)=C1 KUTQDQOKIMDXDF-UHFFFAOYSA-N 0.000 claims description 2
VWESVLAQODTGIL-UHFFFAOYSA-N n-[1-[(4-bromo-3,5-diethoxyphenyl)methyl]piperidin-4-yl]-3-chloroisoquinolin-1-amine Chemical compound CCOC1=C(Br)C(OCC)=CC(CN2CCC(CC2)NC=2C3=CC=CC=C3C=C(Cl)N=2)=C1 VWESVLAQODTGIL-UHFFFAOYSA-N 0.000 claims description 2
SQTVVYRLYHREDL-UHFFFAOYSA-N n-[1-[(4-bromo-3,5-diethoxyphenyl)methyl]piperidin-4-yl]-5-(2h-tetrazol-5-yl)pyridin-2-amine Chemical compound CCOC1=C(Br)C(OCC)=CC(CN2CCC(CC2)NC=2N=CC(=CC=2)C=2NN=NN=2)=C1 SQTVVYRLYHREDL-UHFFFAOYSA-N 0.000 claims description 2
XQDBDCARCJOUOG-UHFFFAOYSA-N n-[1-[(4-bromo-3,5-diethoxyphenyl)methyl]piperidin-4-yl]-8-chloroquinolin-2-amine Chemical compound CCOC1=C(Br)C(OCC)=CC(CN2CCC(CC2)NC=2N=C3C(Cl)=CC=CC3=CC=2)=C1 XQDBDCARCJOUOG-UHFFFAOYSA-N 0.000 claims description 2
FSZBTKRLJBXHIA-UHFFFAOYSA-N n-[1-[(4-chloro-3,5-diethoxyphenyl)methyl]piperidin-4-yl]quinolin-2-amine Chemical compound CCOC1=C(Cl)C(OCC)=CC(CN2CCC(CC2)NC=2N=C3C=CC=CC3=CC=2)=C1 FSZBTKRLJBXHIA-UHFFFAOYSA-N 0.000 claims description 2
AQSOLEJYAAFSSY-UHFFFAOYSA-N n-[1-[(4-chloro-3-ethoxyphenyl)methyl]piperidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine Chemical compound C1=C(Cl)C(OCC)=CC(CN2CCC(CC2)NC=2C(=CC=CN=2)C(F)(F)F)=C1 AQSOLEJYAAFSSY-UHFFFAOYSA-N 0.000 claims description 2
TUDLIORHJGJKCP-UHFFFAOYSA-N n-[1-[(4-chloro-3-ethoxyphenyl)methyl]piperidin-4-yl]-5-(2h-tetrazol-5-yl)pyridin-2-amine Chemical compound C1=C(Cl)C(OCC)=CC(CN2CCC(CC2)NC=2N=CC(=CC=2)C=2NN=NN=2)=C1 TUDLIORHJGJKCP-UHFFFAOYSA-N 0.000 claims description 2
QLMPPIWQMHGQLS-UHFFFAOYSA-N n-[1-[(4-chloro-3-ethoxyphenyl)methyl]piperidin-4-yl]-5-(trifluoromethyl)pyridin-2-amine Chemical compound C1=C(Cl)C(OCC)=CC(CN2CCC(CC2)NC=2N=CC(=CC=2)C(F)(F)F)=C1 QLMPPIWQMHGQLS-UHFFFAOYSA-N 0.000 claims description 2
GPKTXTUKWKCGSZ-UHFFFAOYSA-N n-[1-[(4-chloro-3-ethoxyphenyl)methyl]piperidin-4-yl]-6-methyl-5-nitropyridin-2-amine Chemical compound C1=C(Cl)C(OCC)=CC(CN2CCC(CC2)NC=2N=C(C)C(=CC=2)[N+]([O-])=O)=C1 GPKTXTUKWKCGSZ-UHFFFAOYSA-N 0.000 claims description 2
TXCXCNPEKCYNJH-UHFFFAOYSA-N n-[1-[(4-chloro-3-ethoxyphenyl)methyl]piperidin-4-yl]isoquinolin-1-amine Chemical compound C1=C(Cl)C(OCC)=CC(CN2CCC(CC2)NC=2C3=CC=CC=C3C=CN=2)=C1 TXCXCNPEKCYNJH-UHFFFAOYSA-N 0.000 claims description 2
FOHRVEPUERVMCP-UHFFFAOYSA-N n-[1-[(4-methoxy-3-propoxyphenyl)methyl]piperidin-4-yl]isoquinolin-1-amine Chemical compound C1=C(OC)C(OCCC)=CC(CN2CCC(CC2)NC=2C3=CC=CC=C3C=CN=2)=C1 FOHRVEPUERVMCP-UHFFFAOYSA-N 0.000 claims description 2
FVXQTWLRXAGFGH-UHFFFAOYSA-N n-[1-[(4-methoxy-3-propoxyphenyl)methyl]piperidin-4-yl]quinolin-2-amine Chemical compound C1=C(OC)C(OCCC)=CC(CN2CCC(CC2)NC=2N=C3C=CC=CC3=CC=2)=C1 FVXQTWLRXAGFGH-UHFFFAOYSA-N 0.000 claims description 2
UMIUIQBWHRXLKZ-UHFFFAOYSA-N n-[1-[(8-ethoxy-2,2-dimethylchromen-6-yl)methyl]piperidin-4-yl]isoquinolin-1-amine Chemical compound C1=CC(C)(C)OC2=C1C=C(CN1CCC(CC1)NC=1C3=CC=CC=C3C=CN=1)C=C2OCC UMIUIQBWHRXLKZ-UHFFFAOYSA-N 0.000 claims description 2
RVJMBTRWEJAQSG-UHFFFAOYSA-N n-[1-[[3,5-di(propan-2-yloxy)phenyl]methyl]piperidin-4-yl]quinolin-2-amine Chemical compound CC(C)OC1=CC(OC(C)C)=CC(CN2CCC(CC2)NC=2N=C3C=CC=CC3=CC=2)=C1 RVJMBTRWEJAQSG-UHFFFAOYSA-N 0.000 claims description 2
201000008482 osteoarthritis Diseases 0.000 claims description 2
206010039073 rheumatoid arthritis Diseases 0.000 claims description 2
208000017520 skin disease Diseases 0.000 claims description 2
150000002431 hydrogen Chemical group 0.000 claims 32
KQDCDDWICFCZNC-UHFFFAOYSA-N 3-chloro-n-[1-[(3-ethoxy-4-methylphenyl)methyl]piperidin-4-yl]isoquinolin-1-amine Chemical compound C1=C(C)C(OCC)=CC(CN2CCC(CC2)NC=2C3=CC=CC=C3C=C(Cl)N=2)=C1 KQDCDDWICFCZNC-UHFFFAOYSA-N 0.000 claims 1
GTVWQEYHFPLKLP-UHFFFAOYSA-N 3-chloro-n-[1-[(4-chloro-3-ethoxyphenyl)methyl]piperidin-4-yl]isoquinolin-1-amine Chemical compound C1=C(Cl)C(OCC)=CC(CN2CCC(CC2)NC=2C3=CC=CC=C3C=C(Cl)N=2)=C1 GTVWQEYHFPLKLP-UHFFFAOYSA-N 0.000 claims 1
OSJCWTUEHAQXOJ-UHFFFAOYSA-N 3-chloro-n-[1-[(4-methoxy-3-propoxyphenyl)methyl]piperidin-4-yl]isoquinolin-1-amine Chemical compound C1=C(OC)C(OCCC)=CC(CN2CCC(CC2)NC=2C3=CC=CC=C3C=C(Cl)N=2)=C1 OSJCWTUEHAQXOJ-UHFFFAOYSA-N 0.000 claims 1
CNJSEMQMTMKUGQ-UHFFFAOYSA-N 4-chloro-n-[1-[(4-chloro-3-ethoxyphenyl)methyl]piperidin-4-yl]quinolin-2-amine Chemical compound C1=C(Cl)C(OCC)=CC(CN2CCC(CC2)NC=2N=C3C=CC=CC3=C(Cl)C=2)=C1 CNJSEMQMTMKUGQ-UHFFFAOYSA-N 0.000 claims 1
JKVGBRZBCBMJNK-UHFFFAOYSA-N 6-[[1-[(3,5-diethoxy-4-fluorophenyl)methyl]piperidin-4-yl]amino]pyridine-3-carboxylic acid Chemical compound CCOC1=C(F)C(OCC)=CC(CN2CCC(CC2)NC=2N=CC(=CC=2)C(O)=O)=C1 JKVGBRZBCBMJNK-UHFFFAOYSA-N 0.000 claims 1
LIJCWPHJGWBFJF-UHFFFAOYSA-N 6-[[1-[(3,5-diethoxyphenyl)methyl]piperidin-4-yl]amino]pyridine-3-carboxylic acid Chemical compound CCOC1=CC(OCC)=CC(CN2CCC(CC2)NC=2N=CC(=CC=2)C(O)=O)=C1 LIJCWPHJGWBFJF-UHFFFAOYSA-N 0.000 claims 1
DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 claims 1
UELTXYAPISXVGA-UHFFFAOYSA-N methyl 2-chloro-6-[[1-[(3,5-diethoxy-4-fluorophenyl)methyl]piperidin-4-yl]amino]pyridine-4-carboxylate Chemical compound CCOC1=C(F)C(OCC)=CC(CN2CCC(CC2)NC=2N=C(Cl)C=C(C=2)C(=O)OC)=C1 UELTXYAPISXVGA-UHFFFAOYSA-N 0.000 claims 1
HAEOCXWXUZOCRH-UHFFFAOYSA-N methyl 5-[[1-[(3,5-diethoxy-4-fluorophenyl)methyl]piperidin-4-yl]amino]pyrazine-2-carboxylate Chemical compound CCOC1=C(F)C(OCC)=CC(CN2CCC(CC2)NC=2N=CC(=NC=2)C(=O)OC)=C1 HAEOCXWXUZOCRH-UHFFFAOYSA-N 0.000 claims 1
VECYQDPHKAJAGZ-UHFFFAOYSA-N methyl 5-[[1-[(3,5-diethoxy-4-pyrrol-1-ylphenyl)methyl]piperidin-4-yl]amino]pyrazine-2-carboxylate Chemical compound C=1C(OCC)=C(N2C=CC=C2)C(OCC)=CC=1CN(CC1)CCC1NC1=CN=C(C(=O)OC)C=N1 VECYQDPHKAJAGZ-UHFFFAOYSA-N 0.000 claims 1
MWYIXDZCERBMTM-UHFFFAOYSA-N methyl 5-[[1-[(4-amino-3,5-diethoxyphenyl)methyl]piperidin-4-yl]amino]pyrazine-2-carboxylate Chemical compound CCOC1=C(N)C(OCC)=CC(CN2CCC(CC2)NC=2N=CC(=NC=2)C(=O)OC)=C1 MWYIXDZCERBMTM-UHFFFAOYSA-N 0.000 claims 1
OBMCWTIFWOGGQJ-UHFFFAOYSA-N methyl 5-[[1-[(8-ethoxy-2,2-dimethylchromen-6-yl)methyl]piperidin-4-yl]amino]pyrazine-2-carboxylate Chemical compound C=1C=2C=CC(C)(C)OC=2C(OCC)=CC=1CN(CC1)CCC1NC1=CN=C(C(=O)OC)C=N1 OBMCWTIFWOGGQJ-UHFFFAOYSA-N 0.000 claims 1
LRXFNAMJUWJYGK-UHFFFAOYSA-N n-(2-acetamidoethyl)-6-[[1-[(4-chloro-3,5-diethoxyphenyl)methyl]piperidin-4-yl]amino]pyridine-3-carboxamide Chemical compound CCOC1=C(Cl)C(OCC)=CC(CN2CCC(CC2)NC=2N=CC(=CC=2)C(=O)NCCNC(C)=O)=C1 LRXFNAMJUWJYGK-UHFFFAOYSA-N 0.000 claims 1
KIVBAOQRVCWVHT-UHFFFAOYSA-N n-[1-[(3,5-diethoxy-4-fluorophenyl)methyl]piperidin-4-yl]-5-(trifluoromethyl)pyridin-2-amine Chemical compound CCOC1=C(F)C(OCC)=CC(CN2CCC(CC2)NC=2N=CC(=CC=2)C(F)(F)F)=C1 KIVBAOQRVCWVHT-UHFFFAOYSA-N 0.000 claims 1
HLCXOEOIKRUTEY-UHFFFAOYSA-N n-[1-[(3,5-diethoxyphenyl)methyl]piperidin-4-yl]quinolin-2-amine Chemical compound CCOC1=CC(OCC)=CC(CN2CCC(CC2)NC=2N=C3C=CC=CC3=CC=2)=C1 HLCXOEOIKRUTEY-UHFFFAOYSA-N 0.000 claims 1
PEDWJNJPDPCCSJ-UHFFFAOYSA-N n-[1-[(3-ethoxy-4-methylphenyl)methyl]piperidin-4-yl]-5-(trifluoromethyl)pyridin-2-amine Chemical compound C1=C(C)C(OCC)=CC(CN2CCC(CC2)NC=2N=CC(=CC=2)C(F)(F)F)=C1 PEDWJNJPDPCCSJ-UHFFFAOYSA-N 0.000 claims 1
VYUDGAZBKHCMKS-UHFFFAOYSA-N n-[1-[(3-ethoxy-4-methylphenyl)methyl]piperidin-4-yl]quinolin-2-amine Chemical compound C1=C(C)C(OCC)=CC(CN2CCC(CC2)NC=2N=C3C=CC=CC3=CC=2)=C1 VYUDGAZBKHCMKS-UHFFFAOYSA-N 0.000 claims 1
OXCWAMDKBAYXMZ-UHFFFAOYSA-N n-[1-[(4-amino-3,5-diethoxyphenyl)methyl]piperidin-4-yl]-3-chloroisoquinolin-1-amine Chemical compound CCOC1=C(N)C(OCC)=CC(CN2CCC(CC2)NC=2C3=CC=CC=C3C=C(Cl)N=2)=C1 OXCWAMDKBAYXMZ-UHFFFAOYSA-N 0.000 claims 1
DSPGYWQESFFFMF-UHFFFAOYSA-N n-[1-[(4-amino-3,5-diethoxyphenyl)methyl]piperidin-4-yl]-4-chloroquinolin-2-amine Chemical compound CCOC1=C(N)C(OCC)=CC(CN2CCC(CC2)NC=2N=C3C=CC=CC3=C(Cl)C=2)=C1 DSPGYWQESFFFMF-UHFFFAOYSA-N 0.000 claims 1
QBJJCWMOLZDOGN-UHFFFAOYSA-N n-[1-[(4-bromo-3,5-diethoxyphenyl)methyl]piperidin-4-yl]-4-methylquinolin-2-amine Chemical compound CCOC1=C(Br)C(OCC)=CC(CN2CCC(CC2)NC=2N=C3C=CC=CC3=C(C)C=2)=C1 QBJJCWMOLZDOGN-UHFFFAOYSA-N 0.000 claims 1
NHNGDTFNKUCPAL-UHFFFAOYSA-N n-[1-[(4-bromo-3,5-diethoxyphenyl)methyl]piperidin-4-yl]isoquinolin-1-amine Chemical compound CCOC1=C(Br)C(OCC)=CC(CN2CCC(CC2)NC=2C3=CC=CC=C3C=CN=2)=C1 NHNGDTFNKUCPAL-UHFFFAOYSA-N 0.000 claims 1
NJCHLOXMSLPGHE-UHFFFAOYSA-N n-[1-[(4-bromo-3,5-diethoxyphenyl)methyl]piperidin-4-yl]quinolin-2-amine Chemical compound CCOC1=C(Br)C(OCC)=CC(CN2CCC(CC2)NC=2N=C3C=CC=CC3=CC=2)=C1 NJCHLOXMSLPGHE-UHFFFAOYSA-N 0.000 claims 1
MQCXOKWSXLSXFQ-UHFFFAOYSA-N n-[1-[(4-chloro-3,5-diethoxyphenyl)methyl]piperidin-4-yl]-5-methylsulfonylpyridin-2-amine Chemical compound CCOC1=C(Cl)C(OCC)=CC(CN2CCC(CC2)NC=2N=CC(=CC=2)S(C)(=O)=O)=C1 MQCXOKWSXLSXFQ-UHFFFAOYSA-N 0.000 claims 1
OQWXNTWOLGWACS-UHFFFAOYSA-N n-[1-[(4-chloro-3-ethoxyphenyl)methyl]piperidin-4-yl]-6-fluoroquinolin-2-amine Chemical compound C1=C(Cl)C(OCC)=CC(CN2CCC(CC2)NC=2N=C3C=CC(F)=CC3=CC=2)=C1 OQWXNTWOLGWACS-UHFFFAOYSA-N 0.000 claims 1
RJNVOHGEFHCWEU-UHFFFAOYSA-N n-[1-[(4-methoxy-3-propoxyphenyl)methyl]piperidin-4-yl]-5-(trifluoromethyl)pyridin-2-amine Chemical compound C1=C(OC)C(OCCC)=CC(CN2CCC(CC2)NC=2N=CC(=CC=2)C(F)(F)F)=C1 RJNVOHGEFHCWEU-UHFFFAOYSA-N 0.000 claims 1
GZDPEQKIPYILAK-UHFFFAOYSA-N n-[1-[[3,5-di(propan-2-yloxy)phenyl]methyl]piperidin-4-yl]isoquinolin-1-amine Chemical compound CC(C)OC1=CC(OC(C)C)=CC(CN2CCC(CC2)NC=2C3=CC=CC=C3C=CN=2)=C1 GZDPEQKIPYILAK-UHFFFAOYSA-N 0.000 claims 1
238000002360 preparation method Methods 0.000 abstract description 10
239000000543 intermediate Substances 0.000 description 472
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 162
239000000243 solution Substances 0.000 description 127
HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 113
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 108
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 105
239000013065 commercial product Substances 0.000 description 97
230000002829 reductive effect Effects 0.000 description 94
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 91
ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 79
238000006243 chemical reaction Methods 0.000 description 78
229940095076 benzaldehyde Drugs 0.000 description 72
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 68
239000011541 reaction mixture Substances 0.000 description 67
230000015572 biosynthetic process Effects 0.000 description 66
239000002904 solvent Substances 0.000 description 65
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 61
239000000203 mixture Substances 0.000 description 58
QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 57
238000003786 synthesis reaction Methods 0.000 description 57
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 57
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 53
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 51
ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 48
239000012074 organic phase Substances 0.000 description 46
IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 44
238000001704 evaporation Methods 0.000 description 43
230000008020 evaporation Effects 0.000 description 43
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 42
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 41
238000000746 purification Methods 0.000 description 41
239000000741 silica gel Substances 0.000 description 40
229910002027 silica gel Inorganic materials 0.000 description 40
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 39
238000004440 column chromatography Methods 0.000 description 38
CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 30
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 30
RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 27
101150041968 CDC13 gene Proteins 0.000 description 27
HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 27
239000012043 crude product Substances 0.000 description 27
VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 27
SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical class N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 26
YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 24
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 23
CYPYTURSJDMMMP-WVCUSYJESA-N (1e,4e)-1,5-diphenylpenta-1,4-dien-3-one;palladium Chemical compound [Pd].[Pd].C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 CYPYTURSJDMMMP-WVCUSYJESA-N 0.000 description 22
150000001412 amines Chemical class 0.000 description 22
229910000027 potassium carbonate Inorganic materials 0.000 description 22
229960000583 acetic acid Drugs 0.000 description 21
238000003756 stirring Methods 0.000 description 21
102000005157 Somatostatin Human genes 0.000 description 20
108010056088 Somatostatin Proteins 0.000 description 20
238000004007 reversed phase HPLC Methods 0.000 description 20
FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 19
238000010438 heat treatment Methods 0.000 description 19
BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 19
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 18
239000013058 crude material Substances 0.000 description 18
239000000047 product Substances 0.000 description 18
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 17
NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 description 17
238000010511 deprotection reaction Methods 0.000 description 16
238000005755 formation reaction Methods 0.000 description 16
239000011570 nicotinamide Substances 0.000 description 16
229960003966 nicotinamide Drugs 0.000 description 16
229960000553 somatostatin Drugs 0.000 description 16
102000004877 Insulin Human genes 0.000 description 15
239000000460 chlorine Substances 0.000 description 15
229940125396 insulin Drugs 0.000 description 15
229910052943 magnesium sulfate Inorganic materials 0.000 description 15
235000019341 magnesium sulphate Nutrition 0.000 description 15
DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 15
108090001061 Insulin Proteins 0.000 description 14
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 14
238000003820 Medium-pressure liquid chromatography Methods 0.000 description 14
JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 14
KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 14
AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 14
125000006239 protecting group Chemical group 0.000 description 14
102000005962 receptors Human genes 0.000 description 14
108020003175 receptors Proteins 0.000 description 14
150000003053 piperidines Chemical class 0.000 description 13
239000007787 solid Substances 0.000 description 13
239000012298 atmosphere Substances 0.000 description 12
230000000694 effects Effects 0.000 description 12
239000003921 oil Substances 0.000 description 12
235000019198 oils Nutrition 0.000 description 12
BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 12
239000002775 capsule Substances 0.000 description 11
BLQIRGVINPDUSC-UHFFFAOYSA-N 4-chloro-3-ethoxybenzaldehyde Chemical compound CCOC1=CC(C=O)=CC=C1Cl BLQIRGVINPDUSC-UHFFFAOYSA-N 0.000 description 10
CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 10
239000012876 carrier material Substances 0.000 description 10
125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 10
239000007858 starting material Substances 0.000 description 10
125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 10
FZZMTSNZRBFGGU-UHFFFAOYSA-N 2-chloro-7-fluoroquinazolin-4-amine Chemical compound FC1=CC=C2C(N)=NC(Cl)=NC2=C1 FZZMTSNZRBFGGU-UHFFFAOYSA-N 0.000 description 9
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 9
NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 9
238000001914 filtration Methods 0.000 description 9
BCIIMDOZSUCSEN-UHFFFAOYSA-N piperidin-4-amine Chemical class NC1CCNCC1 BCIIMDOZSUCSEN-UHFFFAOYSA-N 0.000 description 9
239000011780 sodium chloride Substances 0.000 description 9
LZRDHSFPLUWYAX-UHFFFAOYSA-N tert-butyl 4-aminopiperidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCC(N)CC1 LZRDHSFPLUWYAX-UHFFFAOYSA-N 0.000 description 9
IFELWTOFCUUHBY-UHFFFAOYSA-N 3-ethoxy-4-methylbenzaldehyde Chemical compound CCOC1=CC(C=O)=CC=C1C IFELWTOFCUUHBY-UHFFFAOYSA-N 0.000 description 8
CNPURSDMOWDNOQ-UHFFFAOYSA-N 4-methoxy-7h-pyrrolo[2,3-d]pyrimidin-2-amine Chemical compound COC1=NC(N)=NC2=C1C=CN2 CNPURSDMOWDNOQ-UHFFFAOYSA-N 0.000 description 8
210000004027 cell Anatomy 0.000 description 8
238000001816 cooling Methods 0.000 description 8
CBOQJANXLMLOSS-UHFFFAOYSA-N ethyl vanillin Chemical compound CCOC1=CC(C=O)=CC=C1O CBOQJANXLMLOSS-UHFFFAOYSA-N 0.000 description 8
JVTZFYYHCGSXJV-UHFFFAOYSA-N isovanillin Chemical compound COC1=CC=C(C=O)C=C1O JVTZFYYHCGSXJV-UHFFFAOYSA-N 0.000 description 8
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 8
235000005152 nicotinamide Nutrition 0.000 description 8
KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 8
LXNAVEXFUKBNMK-UHFFFAOYSA-N palladium(II) acetate Substances [Pd].CC(O)=O.CC(O)=O LXNAVEXFUKBNMK-UHFFFAOYSA-N 0.000 description 8
YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 8
125000004482 piperidin-4-yl group Chemical group N1CCC(CC1)* 0.000 description 8
230000028327 secretion Effects 0.000 description 8
HOMRAVAJFJLQLJ-UHFFFAOYSA-N 3,5-diethoxy-4-fluorobenzaldehyde Chemical compound CCOC1=CC(C=O)=CC(OCC)=C1F HOMRAVAJFJLQLJ-UHFFFAOYSA-N 0.000 description 7
PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 7
CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 7
YNBADRVTZLEFNH-UHFFFAOYSA-N Methyl nicotinate Natural products COC(=O)C1=CC=CN=C1 YNBADRVTZLEFNH-UHFFFAOYSA-N 0.000 description 7
SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 7
PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 7
201000010099 disease Diseases 0.000 description 7
229920000159 gelatin Polymers 0.000 description 7
235000019322 gelatine Nutrition 0.000 description 7
239000004615 ingredient Substances 0.000 description 7
239000007788 liquid Substances 0.000 description 7
239000000126 substance Substances 0.000 description 7
150000003512 tertiary amines Chemical class 0.000 description 7
RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 7
239000001431 2-methylbenzaldehyde Substances 0.000 description 6
RVJSOGIYAICWMA-UHFFFAOYSA-N 3,5-di(propan-2-yloxy)benzaldehyde Chemical compound CC(C)OC1=CC(OC(C)C)=CC(C=O)=C1 RVJSOGIYAICWMA-UHFFFAOYSA-N 0.000 description 6
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 6
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
239000001828 Gelatine Substances 0.000 description 6
DTHNMHAUYICORS-KTKZVXAJSA-N Glucagon-like peptide 1 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 DTHNMHAUYICORS-KTKZVXAJSA-N 0.000 description 6
102400000322 Glucagon-like peptide 1 Human genes 0.000 description 6
101800000224 Glucagon-like peptide 1 Proteins 0.000 description 6
DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 6
230000002378 acidificating effect Effects 0.000 description 6
239000005557 antagonist Substances 0.000 description 6
239000008346 aqueous phase Substances 0.000 description 6
239000007795 chemical reaction product Substances 0.000 description 6
239000003795 chemical substances by application Substances 0.000 description 6
229910052801 chlorine Inorganic materials 0.000 description 6
229940125782 compound 2 Drugs 0.000 description 6
229940113088 dimethylacetamide Drugs 0.000 description 6
125000000524 functional group Chemical group 0.000 description 6
239000005457 ice water Substances 0.000 description 6
RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
239000003446 ligand Substances 0.000 description 6
NUJOXMJBOLGQSY-UHFFFAOYSA-N manganese dioxide Inorganic materials O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 description 6
239000012528 membrane Substances 0.000 description 6
BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 6
229910052757 nitrogen Inorganic materials 0.000 description 6
235000011181 potassium carbonates Nutrition 0.000 description 6
239000000725 suspension Substances 0.000 description 6
239000003826 tablet Substances 0.000 description 6
FLBAYUMRQUHISI-UHFFFAOYSA-N 1,8-naphthyridine Chemical compound N1=CC=CC2=CC=CN=C21 FLBAYUMRQUHISI-UHFFFAOYSA-N 0.000 description 5
WIPMWRCUOVSCDQ-UHFFFAOYSA-N 3,5-diethoxybenzaldehyde Chemical compound CCOC1=CC(OCC)=CC(C=O)=C1 WIPMWRCUOVSCDQ-UHFFFAOYSA-N 0.000 description 5
VAMZHXWLGRQSJS-UHFFFAOYSA-N 3-ethoxy-4-methoxybenzaldehyde Chemical compound CCOC1=CC(C=O)=CC=C1OC VAMZHXWLGRQSJS-UHFFFAOYSA-N 0.000 description 5
KDMBOQMYUQZULT-UHFFFAOYSA-N 5-methylsulfonyl-n-piperidin-4-ylpyridin-2-amine Chemical compound N1=CC(S(=O)(=O)C)=CC=C1NC1CCNCC1 KDMBOQMYUQZULT-UHFFFAOYSA-N 0.000 description 5
101100139845 Caenorhabditis elegans rac-2 gene Proteins 0.000 description 5
ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 5
GISRWBROCYNDME-PELMWDNLSA-N F[C@H]1[C@H]([C@H](NC1=O)COC1=NC=CC2=CC(=C(C=C12)OC)C(=O)N)C Chemical compound F[C@H]1[C@H]([C@H](NC1=O)COC1=NC=CC2=CC(=C(C=C12)OC)C(=O)N)C GISRWBROCYNDME-PELMWDNLSA-N 0.000 description 5
MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 5
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 5
238000007126 N-alkylation reaction Methods 0.000 description 5
KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 5
150000001298 alcohols Chemical class 0.000 description 5
238000005804 alkylation reaction Methods 0.000 description 5
125000004429 atom Chemical group 0.000 description 5
WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 5
SIPUZPBQZHNSDW-UHFFFAOYSA-N bis(2-methylpropyl)aluminum Chemical compound CC(C)C[Al]CC(C)C SIPUZPBQZHNSDW-UHFFFAOYSA-N 0.000 description 5
239000012267 brine Substances 0.000 description 5
239000003153 chemical reaction reagent Substances 0.000 description 5
238000007796 conventional method Methods 0.000 description 5
WHOBZBLBTZHMGY-UHFFFAOYSA-N ditert-butyl(ethyl)phosphane Chemical compound CCP(C(C)(C)C)C(C)(C)C WHOBZBLBTZHMGY-UHFFFAOYSA-N 0.000 description 5
230000008030 elimination Effects 0.000 description 5
238000003379 elimination reaction Methods 0.000 description 5
150000004678 hydrides Chemical class 0.000 description 5
125000002768 hydroxyalkyl group Chemical group 0.000 description 5
201000001421 hyperglycemia Diseases 0.000 description 5
AKQZEFRALAUBFS-UHFFFAOYSA-N ilamine Natural products COC(C)C(O)(C(=O)OCC1=CCN2CCCC12)C(C)(C)O AKQZEFRALAUBFS-UHFFFAOYSA-N 0.000 description 5
239000008101 lactose Substances 0.000 description 5
229960001238 methylnicotinate Drugs 0.000 description 5
150000003222 pyridines Chemical class 0.000 description 5
238000010992 reflux Methods 0.000 description 5
239000011734 sodium Substances 0.000 description 5
229910000029 sodium carbonate Inorganic materials 0.000 description 5
235000017550 sodium carbonate Nutrition 0.000 description 5
HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 5
125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 5
238000012360 testing method Methods 0.000 description 5
230000009466 transformation Effects 0.000 description 5
238000000844 transformation Methods 0.000 description 5
QYYZXEPEVBXNNA-QGZVFWFLSA-N (1R)-2-acetyl-N-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl]-5-methylsulfonyl-1,3-dihydroisoindole-1-carboxamide Chemical compound C(C)(=O)N1[C@H](C2=CC=C(C=C2C1)S(=O)(=O)C)C(=O)NC1=CC=C(C=C1)C(C(F)(F)F)(C(F)(F)F)O QYYZXEPEVBXNNA-QGZVFWFLSA-N 0.000 description 4
SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 4
GPWNWKWQOLEVEQ-UHFFFAOYSA-N 2,4-diaminopyrimidine-5-carbaldehyde Chemical compound NC1=NC=C(C=O)C(N)=N1 GPWNWKWQOLEVEQ-UHFFFAOYSA-N 0.000 description 4
RDCJTCLPIAILIW-UHFFFAOYSA-N 2-(piperidin-4-ylamino)pyridine-4-carbonitrile;dihydrochloride Chemical compound Cl.Cl.N#CC1=CC=NC(NC2CCNCC2)=C1 RDCJTCLPIAILIW-UHFFFAOYSA-N 0.000 description 4
HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 4
OQGTYVGUCWWYNK-UHFFFAOYSA-N 4-methoxy-3-propoxybenzaldehyde Chemical compound CCCOC1=CC(C=O)=CC=C1OC OQGTYVGUCWWYNK-UHFFFAOYSA-N 0.000 description 4
PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 4
QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 4
XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 4
OHCQJHSOBUTRHG-KGGHGJDLSA-N FORSKOLIN Chemical compound O=C([C@@]12O)C[C@](C)(C=C)O[C@]1(C)[C@@H](OC(=O)C)[C@@H](O)[C@@H]1[C@]2(C)[C@@H](O)CCC1(C)C OHCQJHSOBUTRHG-KGGHGJDLSA-N 0.000 description 4
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 4
WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 4
229920000168 Microcrystalline cellulose Polymers 0.000 description 4
PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 4
XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 4
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
108050001286 Somatostatin Receptor Proteins 0.000 description 4
102000011096 Somatostatin receptor Human genes 0.000 description 4
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
239000004480 active ingredient Substances 0.000 description 4
230000029936 alkylation Effects 0.000 description 4
230000027455 binding Effects 0.000 description 4
229940125904 compound 1 Drugs 0.000 description 4
229940088597 hormone Drugs 0.000 description 4
239000005556 hormone Substances 0.000 description 4
229910052740 iodine Inorganic materials 0.000 description 4
235000019359 magnesium stearate Nutrition 0.000 description 4
239000008108 microcrystalline cellulose Substances 0.000 description 4
229940016286 microcrystalline cellulose Drugs 0.000 description 4
235000019813 microcrystalline cellulose Nutrition 0.000 description 4
BTFQKIATRPGRBS-UHFFFAOYSA-N o-tolualdehyde Chemical compound CC1=CC=CC=C1C=O BTFQKIATRPGRBS-UHFFFAOYSA-N 0.000 description 4
ZRSNZINYAWTAHE-UHFFFAOYSA-N p-methoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C=C1 ZRSNZINYAWTAHE-UHFFFAOYSA-N 0.000 description 4
FXLOVSHXALFLKQ-UHFFFAOYSA-N p-tolualdehyde Chemical compound CC1=CC=C(C=O)C=C1 FXLOVSHXALFLKQ-UHFFFAOYSA-N 0.000 description 4
210000000496 pancreas Anatomy 0.000 description 4
229920005862 polyol Polymers 0.000 description 4
150000003077 polyols Chemical class 0.000 description 4
239000000843 powder Substances 0.000 description 4
108090000623 proteins and genes Proteins 0.000 description 4
YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
150000003335 secondary amines Chemical class 0.000 description 4
208000024891 symptom Diseases 0.000 description 4
DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 4
239000001993 wax Substances 0.000 description 4
YXEQMNUWZJJSAA-UHFFFAOYSA-N 1-[(4-chloro-3-ethoxyphenyl)methyl]piperidin-4-amine Chemical compound C1=C(Cl)C(OCC)=CC(CN2CCC(N)CC2)=C1 YXEQMNUWZJJSAA-UHFFFAOYSA-N 0.000 description 3
RHZRJGAFIQFUEJ-UHFFFAOYSA-N 2,6-dichloro-4-(methoxymethyl)pyridine Chemical compound COCC1=CC(Cl)=NC(Cl)=C1 RHZRJGAFIQFUEJ-UHFFFAOYSA-N 0.000 description 3
PKZJLOCLABXVMC-UHFFFAOYSA-N 2-Methoxybenzaldehyde Chemical compound COC1=CC=CC=C1C=O PKZJLOCLABXVMC-UHFFFAOYSA-N 0.000 description 3
RSZSTJJGUJGAQX-UHFFFAOYSA-N 2-[6-(piperidin-4-ylamino)pyridin-3-yl]oxyacetonitrile Chemical compound N1=CC(OCC#N)=CC=C1NC1CCNCC1 RSZSTJJGUJGAQX-UHFFFAOYSA-N 0.000 description 3
USAYWGMYCNWTGO-UHFFFAOYSA-N 2-chloro-6-fluoroquinoline Chemical compound N1=C(Cl)C=CC2=CC(F)=CC=C21 USAYWGMYCNWTGO-UHFFFAOYSA-N 0.000 description 3
MRNFSCMXRMZCBA-UHFFFAOYSA-N 3,5-diethoxy-4-iodobenzaldehyde Chemical compound CCOC1=CC(C=O)=CC(OCC)=C1I MRNFSCMXRMZCBA-UHFFFAOYSA-N 0.000 description 3
NIWHPGZKBRXLMN-UHFFFAOYSA-N 3-chloro-n-[1-[[3,5-diethoxy-4-(4-fluorophenyl)phenyl]methyl]piperidin-4-yl]isoquinolin-1-amine Chemical compound CCOC1=CC(CN2CCC(CC2)NC=2C3=CC=CC=C3C=C(Cl)N=2)=CC(OCC)=C1C1=CC=C(F)C=C1 NIWHPGZKBRXLMN-UHFFFAOYSA-N 0.000 description 3
KKUVUTWNGIFGIP-UHFFFAOYSA-N 3-chloro-n-piperidin-4-ylisoquinolin-1-amine;dihydrochloride Chemical compound Cl.Cl.N=1C(Cl)=CC2=CC=CC=C2C=1NC1CCNCC1 KKUVUTWNGIFGIP-UHFFFAOYSA-N 0.000 description 3
HZNOPWKQZZXRIF-UHFFFAOYSA-N 3-ethoxy-4-fluorobenzaldehyde Chemical compound CCOC1=CC(C=O)=CC=C1F HZNOPWKQZZXRIF-UHFFFAOYSA-N 0.000 description 3
OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 3
QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 3
WTLQHORYSMINSJ-UHFFFAOYSA-N 4-[[1-[(3-ethoxy-4-methoxyphenyl)methyl]piperidin-4-yl]amino]benzonitrile Chemical compound C1=C(OC)C(OCC)=CC(CN2CCC(CC2)NC=2C=CC(=CC=2)C#N)=C1 WTLQHORYSMINSJ-UHFFFAOYSA-N 0.000 description 3
VUGWJDGEPZNBKZ-UHFFFAOYSA-N 4-methoxy-3-(2-methylpropoxy)benzaldehyde Chemical compound COC1=CC=C(C=O)C=C1OCC(C)C VUGWJDGEPZNBKZ-UHFFFAOYSA-N 0.000 description 3
MEFNDPLQHJAHOI-UHFFFAOYSA-N 6-[[1-[(3-ethoxy-4-hydroxyphenyl)methyl]piperidin-4-yl]amino]-4-(trifluoromethyl)pyridine-3-carboxylic acid Chemical compound C1=C(O)C(OCC)=CC(CN2CCC(CC2)NC=2N=CC(=C(C=2)C(F)(F)F)C(O)=O)=C1 MEFNDPLQHJAHOI-UHFFFAOYSA-N 0.000 description 3
HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 3
MDTFILVSWQUDRQ-UHFFFAOYSA-N 8-chloro-n-piperidin-4-ylquinolin-2-amine;dihydrochloride Chemical compound Cl.Cl.N1=C2C(Cl)=CC=CC2=CC=C1NC1CCNCC1 MDTFILVSWQUDRQ-UHFFFAOYSA-N 0.000 description 3
239000005711 Benzoic acid Substances 0.000 description 3
239000007821 HATU Substances 0.000 description 3
AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 3
238000005481 NMR spectroscopy Methods 0.000 description 3
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Natural products OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 3
OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 3
229940100389 Sulfonylurea Drugs 0.000 description 3
229940123464 Thiazolidinedione Drugs 0.000 description 3
OEQVYZGFHWLRGC-UHFFFAOYSA-N [6-(piperidin-4-ylamino)pyridin-3-yl] methanesulfonate Chemical compound N1=CC(OS(=O)(=O)C)=CC=C1NC1CCNCC1 OEQVYZGFHWLRGC-UHFFFAOYSA-N 0.000 description 3
125000004453 alkoxycarbonyl group Chemical group 0.000 description 3
239000003472 antidiabetic agent Substances 0.000 description 3
229910052786 argon Inorganic materials 0.000 description 3
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 3
MTZQAGJQAFMTAQ-UHFFFAOYSA-N benzoic acid ethyl ester Natural products CCOC(=O)C1=CC=CC=C1 MTZQAGJQAFMTAQ-UHFFFAOYSA-N 0.000 description 3
150000004283 biguanides Chemical class 0.000 description 3
239000006227 byproduct Substances 0.000 description 3
229910000024 caesium carbonate Inorganic materials 0.000 description 3
150000001735 carboxylic acids Chemical class 0.000 description 3
238000004587 chromatography analysis Methods 0.000 description 3
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
239000012141 concentrate Substances 0.000 description 3
235000008504 concentrate Nutrition 0.000 description 3
125000000753 cycloalkyl group Chemical group 0.000 description 3
150000002148 esters Chemical class 0.000 description 3
BGNFNUXEBYGZAM-UHFFFAOYSA-N ethyl 4-amino-3,5-diethoxybenzoate Chemical compound CCOC(=O)C1=CC(OCC)=C(N)C(OCC)=C1 BGNFNUXEBYGZAM-UHFFFAOYSA-N 0.000 description 3
239000003925 fat Substances 0.000 description 3
235000019253 formic acid Nutrition 0.000 description 3
125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
150000007529 inorganic bases Chemical class 0.000 description 3
HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 3
GACFTYIPBQCTQB-UHFFFAOYSA-N isoquinoline;dihydrochloride Chemical compound Cl.Cl.C1=NC=CC2=CC=CC=C21 GACFTYIPBQCTQB-UHFFFAOYSA-N 0.000 description 3
125000000842 isoxazolyl group Chemical group 0.000 description 3
KXXVTSCFGRGCTA-UHFFFAOYSA-N methyl 2-chloro-6-(piperidin-4-ylamino)pyridine-4-carboxylate Chemical compound COC(=O)C1=CC(Cl)=NC(NC2CCNCC2)=C1 KXXVTSCFGRGCTA-UHFFFAOYSA-N 0.000 description 3
BCOIUCZETMDLDS-UHFFFAOYSA-N methyl 6-(piperidin-4-ylamino)-4-(trifluoromethyl)pyridine-3-carboxylate;dihydrochloride Chemical compound Cl.Cl.C1=C(C(F)(F)F)C(C(=O)OC)=CN=C1NC1CCNCC1 BCOIUCZETMDLDS-UHFFFAOYSA-N 0.000 description 3
IOCVSGSXZOZHJL-UHFFFAOYSA-N n-piperidin-4-yl-5-(2h-tetrazol-5-yl)pyridin-2-amine;dihydrochloride Chemical compound Cl.Cl.C1CNCCC1NC1=CC=C(C=2NN=NN=2)C=N1 IOCVSGSXZOZHJL-UHFFFAOYSA-N 0.000 description 3
235000001968 nicotinic acid Nutrition 0.000 description 3
238000010534 nucleophilic substitution reaction Methods 0.000 description 3
229910052760 oxygen Inorganic materials 0.000 description 3
239000001301 oxygen Substances 0.000 description 3
239000000825 pharmaceutical preparation Substances 0.000 description 3
239000012071 phase Substances 0.000 description 3
235000015320 potassium carbonate Nutrition 0.000 description 3
150000003141 primary amines Chemical class 0.000 description 3
102000004169 proteins and genes Human genes 0.000 description 3
239000000700 radioactive tracer Substances 0.000 description 3
239000002994 raw material Substances 0.000 description 3
239000000376 reactant Substances 0.000 description 3
230000035484 reaction time Effects 0.000 description 3
230000009467 reduction Effects 0.000 description 3
238000006722 reduction reaction Methods 0.000 description 3
229910000104 sodium hydride Inorganic materials 0.000 description 3
239000007921 spray Substances 0.000 description 3
239000000454 talc Substances 0.000 description 3
229910052623 talc Inorganic materials 0.000 description 3
GSGQLPAZTVJHOX-UHFFFAOYSA-N tert-butyl 4-[(5-cyanopyridin-2-yl)amino]piperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1NC1=CC=C(C#N)C=N1 GSGQLPAZTVJHOX-UHFFFAOYSA-N 0.000 description 3
238000002560 therapeutic procedure Methods 0.000 description 3
150000001467 thiazolidinediones Chemical class 0.000 description 3
DLFVBJFMPXGRIB-UHFFFAOYSA-N thioacetamide Natural products CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 3
239000010936 titanium Substances 0.000 description 3
235000015112 vegetable and seed oil Nutrition 0.000 description 3
239000008158 vegetable oil Substances 0.000 description 3
YKJXCZGWLSFQQQ-UHFFFAOYSA-N (3,5-diethoxy-4-fluorophenyl)methanol Chemical compound CCOC1=CC(CO)=CC(OCC)=C1F YKJXCZGWLSFQQQ-UHFFFAOYSA-N 0.000 description 2
VTLXARFHHVQLED-UHFFFAOYSA-N (4-chloro-3,5-diethoxyphenyl)methanol Chemical compound CCOC1=CC(CO)=CC(OCC)=C1Cl VTLXARFHHVQLED-UHFFFAOYSA-N 0.000 description 2
BRGZEQXWZWBPJH-UHFFFAOYSA-N 1,3-dichloroisoquinoline Chemical class C1=CC=C2C(Cl)=NC(Cl)=CC2=C1 BRGZEQXWZWBPJH-UHFFFAOYSA-N 0.000 description 2
ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 2
ZCIFJVGRRYSVNH-UHFFFAOYSA-N 1-[(3-ethoxy-4-methoxyphenyl)methyl]piperidin-4-one Chemical compound C1=C(OC)C(OCC)=CC(CN2CCC(=O)CC2)=C1 ZCIFJVGRRYSVNH-UHFFFAOYSA-N 0.000 description 2
LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 2
XTMPMAALQUQJOO-UHFFFAOYSA-N 2,3-di(propan-2-yloxy)benzaldehyde Chemical compound CC(C)OC1=CC=CC(C=O)=C1OC(C)C XTMPMAALQUQJOO-UHFFFAOYSA-N 0.000 description 2
FILKGCRCWDMBKA-UHFFFAOYSA-N 2,6-dichloropyridine Chemical class ClC1=CC=CC(Cl)=N1 FILKGCRCWDMBKA-UHFFFAOYSA-N 0.000 description 2
JOYFGJXEKRZRGI-UHFFFAOYSA-N 2,7-dichloro-4-(methoxymethyl)quinoline Chemical compound ClC1=CC=C2C(COC)=CC(Cl)=NC2=C1 JOYFGJXEKRZRGI-UHFFFAOYSA-N 0.000 description 2
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
JFZJMSDDOOAOIV-UHFFFAOYSA-N 2-chloro-5-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)N=C1 JFZJMSDDOOAOIV-UHFFFAOYSA-N 0.000 description 2
ZPRIFYZNQOLSDC-UHFFFAOYSA-N 2-chloro-6-[[1-[[3,5-diethoxy-4-(4-fluorophenyl)phenyl]methyl]piperidin-4-yl]amino]pyridine-4-carboxylic acid Chemical compound C=1C(OCC)=C(C=2C=CC(F)=CC=2)C(OCC)=CC=1CN(CC1)CCC1NC1=CC(C(O)=O)=CC(Cl)=N1 ZPRIFYZNQOLSDC-UHFFFAOYSA-N 0.000 description 2
OFUFXTHGZWIDDB-UHFFFAOYSA-N 2-chloroquinoline Chemical compound C1=CC=CC2=NC(Cl)=CC=C21 OFUFXTHGZWIDDB-UHFFFAOYSA-N 0.000 description 2
FZFSNUPYWXJXOT-UHFFFAOYSA-N 2h-chromene-6-carbaldehyde Chemical compound O1CC=CC2=CC(C=O)=CC=C21 FZFSNUPYWXJXOT-UHFFFAOYSA-N 0.000 description 2
OHQYXBAZSGBEJO-UHFFFAOYSA-N 3,5-diethoxy-4-pyrrol-1-ylbenzaldehyde Chemical compound CCOC1=CC(C=O)=CC(OCC)=C1N1C=CC=C1 OHQYXBAZSGBEJO-UHFFFAOYSA-N 0.000 description 2
HAQLHRYUDBKTJG-UHFFFAOYSA-N 3,5-dihydroxybenzaldehyde Chemical compound OC1=CC(O)=CC(C=O)=C1 HAQLHRYUDBKTJG-UHFFFAOYSA-N 0.000 description 2
WCDOHYCNDDOZEG-UHFFFAOYSA-N 3-[6-(piperidin-4-ylamino)pyridin-3-yl]oxypropan-1-ol Chemical compound N1=CC(OCCCO)=CC=C1NC1CCNCC1 WCDOHYCNDDOZEG-UHFFFAOYSA-N 0.000 description 2
JGOSFXULPPRENR-UHFFFAOYSA-N 3-ethoxy-4-methoxypiperidin-4-amine Chemical compound C(C)OC1CNCCC1(OC)N JGOSFXULPPRENR-UHFFFAOYSA-N 0.000 description 2
QZMGMXBYJZVAJN-UHFFFAOYSA-N 3-ethoxybenzaldehyde Chemical compound CCOC1=CC=CC(C=O)=C1 QZMGMXBYJZVAJN-UHFFFAOYSA-N 0.000 description 2
MIQBQKAXBNXBCQ-UHFFFAOYSA-N 3-hydroxy-5-propan-2-yloxybenzaldehyde Chemical compound CC(C)OC1=CC(O)=CC(C=O)=C1 MIQBQKAXBNXBCQ-UHFFFAOYSA-N 0.000 description 2
GFFJBSXKNZDYOJ-UHFFFAOYSA-N 3-propoxybenzaldehyde Chemical compound CCCOC1=CC=CC(C=O)=C1 GFFJBSXKNZDYOJ-UHFFFAOYSA-N 0.000 description 2
125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 2
NQNQKLBWDARKDG-UHFFFAOYSA-N 4-amino-1-piperidinecarboxylic acid Chemical compound NC1CCN(C(O)=O)CC1 NQNQKLBWDARKDG-UHFFFAOYSA-N 0.000 description 2
ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
CVGUZCQQVNVWQO-UHFFFAOYSA-N 4-chloro-3,5-diethoxybenzaldehyde Chemical compound CCOC1=CC(C=O)=CC(OCC)=C1Cl CVGUZCQQVNVWQO-UHFFFAOYSA-N 0.000 description 2
AEKVBBNGWBBYLL-UHFFFAOYSA-N 4-fluorobenzonitrile Chemical compound FC1=CC=C(C#N)C=C1 AEKVBBNGWBBYLL-UHFFFAOYSA-N 0.000 description 2
GTWFSDYGKCARNX-UHFFFAOYSA-N 4-methyl-n-piperidin-4-ylquinolin-2-amine;dihydrochloride Chemical compound Cl.Cl.N=1C2=CC=CC=C2C(C)=CC=1NC1CCNCC1 GTWFSDYGKCARNX-UHFFFAOYSA-N 0.000 description 2
NMXNVNMJOOUKEL-UHFFFAOYSA-N 6-(piperidin-4-ylamino)pyridine-3-carbonitrile;dihydrochloride Chemical compound Cl.Cl.N1=CC(C#N)=CC=C1NC1CCNCC1 NMXNVNMJOOUKEL-UHFFFAOYSA-N 0.000 description 2
MWUXNXSTRNSNNY-UHFFFAOYSA-N 6-(piperidin-4-ylamino)pyridine-3-carboxamide;dihydrochloride Chemical compound Cl.Cl.N1=CC(C(=O)N)=CC=C1NC1CCNCC1 MWUXNXSTRNSNNY-UHFFFAOYSA-N 0.000 description 2
RENDYSHMRXXULC-UHFFFAOYSA-N 6-(piperidin-4-ylamino)pyridine-3-carboxylic acid;dihydrochloride Chemical compound Cl.Cl.N1=CC(C(=O)O)=CC=C1NC1CCNCC1 RENDYSHMRXXULC-UHFFFAOYSA-N 0.000 description 2
KZLCZJBRFFMHTK-UHFFFAOYSA-N 6-[[1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-4-yl]amino]pyridine-3-carboxylic acid Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1NC1=CC=C(C(O)=O)C=N1 KZLCZJBRFFMHTK-UHFFFAOYSA-N 0.000 description 2
JEAUOIJMOLSLCO-UHFFFAOYSA-N 6-[[1-[(4-chloro-3,5-diethoxyphenyl)methyl]piperidin-4-yl]amino]pyridine-3-carboxamide Chemical compound CCOC1=C(Cl)C(OCC)=CC(CN2CCC(CC2)NC=2N=CC(=CC=2)C(N)=O)=C1 JEAUOIJMOLSLCO-UHFFFAOYSA-N 0.000 description 2
ORIQLMBUPMABDV-UHFFFAOYSA-N 6-chloropyridine-3-carbonitrile Chemical compound ClC1=CC=C(C#N)C=N1 ORIQLMBUPMABDV-UHFFFAOYSA-N 0.000 description 2
NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
229940123208 Biguanide Drugs 0.000 description 2
WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
LZFJTWJGPZVTDJ-UHFFFAOYSA-N C(C)(C)(C)[SiH2]OC(C=1C=CC(=C(C1)O)F)(C)C Chemical compound C(C)(C)(C)[SiH2]OC(C=1C=CC(=C(C1)O)F)(C)C LZFJTWJGPZVTDJ-UHFFFAOYSA-N 0.000 description 2
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
229920002261 Corn starch Polymers 0.000 description 2
SUZLHDUTVMZSEV-UHFFFAOYSA-N Deoxycoleonol Natural products C12C(=O)CC(C)(C=C)OC2(C)C(OC(=O)C)C(O)C2C1(C)C(O)CCC2(C)C SUZLHDUTVMZSEV-UHFFFAOYSA-N 0.000 description 2
JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 2
VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
102400000326 Glucagon-like peptide 2 Human genes 0.000 description 2
101800000221 Glucagon-like peptide 2 Proteins 0.000 description 2
AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
239000007995 HEPES buffer Substances 0.000 description 2
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
208000007976 Ketosis Diseases 0.000 description 2
239000002841 Lewis acid Substances 0.000 description 2
241001465754 Metazoa Species 0.000 description 2
YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
239000004146 Propane-1,2-diol Substances 0.000 description 2
LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
YASAKCUCGLMORW-UHFFFAOYSA-N Rosiglitazone Chemical compound C=1C=CC=NC=1N(C)CCOC(C=C1)=CC=C1CC1SC(=O)NC1=O YASAKCUCGLMORW-UHFFFAOYSA-N 0.000 description 2
KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
229940121856 Somatostatin receptor antagonist Drugs 0.000 description 2
NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 description 2
239000007983 Tris buffer Substances 0.000 description 2
DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
230000009471 action Effects 0.000 description 2
230000001154 acute effect Effects 0.000 description 2
125000001931 aliphatic group Chemical group 0.000 description 2
125000004183 alkoxy alkyl group Chemical group 0.000 description 2
125000005083 alkoxyalkoxy group Chemical group 0.000 description 2
125000005907 alkyl ester group Chemical group 0.000 description 2
238000010171 animal model Methods 0.000 description 2
125000003118 aryl group Chemical group 0.000 description 2
230000009286 beneficial effect Effects 0.000 description 2
235000010233 benzoic acid Nutrition 0.000 description 2
210000004369 blood Anatomy 0.000 description 2
239000008280 blood Substances 0.000 description 2
210000004204 blood vessel Anatomy 0.000 description 2
GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
229910052794 bromium Inorganic materials 0.000 description 2
125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
150000003857 carboxamides Chemical class 0.000 description 2
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
239000001768 carboxy methyl cellulose Substances 0.000 description 2
150000007942 carboxylates Chemical class 0.000 description 2
150000001732 carboxylic acid derivatives Chemical group 0.000 description 2
230000001684 chronic effect Effects 0.000 description 2
OHCQJHSOBUTRHG-UHFFFAOYSA-N colforsin Natural products OC12C(=O)CC(C)(C=C)OC1(C)C(OC(=O)C)C(O)C1C2(C)C(O)CCC1(C)C OHCQJHSOBUTRHG-UHFFFAOYSA-N 0.000 description 2
239000008120 corn starch Substances 0.000 description 2
238000002425 crystallisation Methods 0.000 description 2
230000008025 crystallization Effects 0.000 description 2
125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 2
238000011161 development Methods 0.000 description 2
WMKGGPCROCCUDY-PHEQNACWSA-N dibenzylideneacetone Chemical compound C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 WMKGGPCROCCUDY-PHEQNACWSA-N 0.000 description 2
FAMRKDQNMBBFBR-BQYQJAHWSA-N diethyl azodicarboxylate Substances CCOC(=O)\N=N\C(=O)OCC FAMRKDQNMBBFBR-BQYQJAHWSA-N 0.000 description 2
125000006001 difluoroethyl group Chemical group 0.000 description 2
125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 2
XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
239000008298 dragée Substances 0.000 description 2
238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 2
125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 2
HTTNDVNWLQPLSI-UHFFFAOYSA-N ethyl 4-chloro-3,5-diethoxybenzoate Chemical compound CCOC(=O)C1=CC(OCC)=C(Cl)C(OCC)=C1 HTTNDVNWLQPLSI-UHFFFAOYSA-N 0.000 description 2
FAMRKDQNMBBFBR-UHFFFAOYSA-N ethyl n-ethoxycarbonyliminocarbamate Chemical compound CCOC(=O)N=NC(=O)OCC FAMRKDQNMBBFBR-UHFFFAOYSA-N 0.000 description 2
238000003818 flash chromatography Methods 0.000 description 2
239000005454 flavour additive Substances 0.000 description 2
239000006260 foam Substances 0.000 description 2
235000013355 food flavoring agent Nutrition 0.000 description 2
238000002825 functional assay Methods 0.000 description 2
239000007903 gelatin capsule Substances 0.000 description 2
TWSALRJGPBVBQU-PKQQPRCHSA-N glucagon-like peptide 2 Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(O)=O)[C@@H](C)CC)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)CC)C1=CC=CC=C1 TWSALRJGPBVBQU-PKQQPRCHSA-N 0.000 description 2
125000005456 glyceride group Chemical group 0.000 description 2
235000011187 glycerol Nutrition 0.000 description 2
239000008187 granular material Substances 0.000 description 2
150000004820 halides Chemical class 0.000 description 2
230000036541 health Effects 0.000 description 2
125000005842 heteroatom Chemical group 0.000 description 2
238000004128 high performance liquid chromatography Methods 0.000 description 2
229910000042 hydrogen bromide Inorganic materials 0.000 description 2
238000001727 in vivo Methods 0.000 description 2
238000002347 injection Methods 0.000 description 2
239000007924 injection Substances 0.000 description 2
150000002500 ions Chemical class 0.000 description 2
125000004254 isoquinolin-1-yl group Chemical group [H]C1=C([H])C2=C([H])C([H])=C([H])C([H])=C2C(*)=N1 0.000 description 2
230000004140 ketosis Effects 0.000 description 2
150000007517 lewis acids Chemical class 0.000 description 2
230000007774 longterm Effects 0.000 description 2
230000010534 mechanism of action Effects 0.000 description 2
XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 description 2
229960003105 metformin Drugs 0.000 description 2
HNQIVZYLYMDVSB-UHFFFAOYSA-N methanesulfonimidic acid Chemical compound CS(N)(=O)=O HNQIVZYLYMDVSB-UHFFFAOYSA-N 0.000 description 2
AKUGRTILKUGVAU-UHFFFAOYSA-N n-[1-[(4-chloro-3,5-diethoxyphenyl)methyl]piperidin-4-yl]-4-methylquinolin-2-amine Chemical compound CCOC1=C(Cl)C(OCC)=CC(CN2CCC(CC2)NC=2N=C3C=CC=CC3=C(C)C=2)=C1 AKUGRTILKUGVAU-UHFFFAOYSA-N 0.000 description 2
MKUCKCXNBXNXAP-UHFFFAOYSA-N n-[3-(piperidin-4-ylamino)phenyl]acetamide;dihydrochloride Chemical compound Cl.Cl.CC(=O)NC1=CC=CC(NC2CCNCC2)=C1 MKUCKCXNBXNXAP-UHFFFAOYSA-N 0.000 description 2
PTAUSNKHBPKZRZ-UHFFFAOYSA-N n-piperidin-4-yl-5-(trifluoromethyl)pyridin-2-amine;dihydrochloride Chemical compound Cl.Cl.N1=CC(C(F)(F)F)=CC=C1NC1CCNCC1 PTAUSNKHBPKZRZ-UHFFFAOYSA-N 0.000 description 2
FOEJQIOHQDJGNG-UHFFFAOYSA-N n-piperidin-4-ylquinolin-2-amine;dihydrochloride Chemical compound Cl.Cl.C1CNCCC1NC1=CC=C(C=CC=C2)C2=N1 FOEJQIOHQDJGNG-UHFFFAOYSA-N 0.000 description 2
239000003538 oral antidiabetic agent Substances 0.000 description 2
150000007530 organic bases Chemical class 0.000 description 2
229910052763 palladium Inorganic materials 0.000 description 2
FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
239000000546 pharmaceutical excipient Substances 0.000 description 2
229910000073 phosphorus hydride Inorganic materials 0.000 description 2
XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
ZNSWGHZWUUFFKV-UHFFFAOYSA-N piperidine;pyridine Chemical compound C1CCNCC1.C1=CC=NC=C1 ZNSWGHZWUUFFKV-UHFFFAOYSA-N 0.000 description 2
239000003880 polar aprotic solvent Substances 0.000 description 2
229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
239000001267 polyvinylpyrrolidone Substances 0.000 description 2
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 2
238000002953 preparative HPLC Methods 0.000 description 2
229960004063 propylene glycol Drugs 0.000 description 2
GPHQHTOMRSGBNZ-UHFFFAOYSA-N pyridine-4-carbonitrile Chemical compound N#CC1=CC=NC=C1 GPHQHTOMRSGBNZ-UHFFFAOYSA-N 0.000 description 2
239000011347 resin Substances 0.000 description 2
229920005989 resin Polymers 0.000 description 2
230000002441 reversible effect Effects 0.000 description 2
229960004889 salicylic acid Drugs 0.000 description 2
229920006395 saturated elastomer Polymers 0.000 description 2
229910052708 sodium Inorganic materials 0.000 description 2
235000017557 sodium bicarbonate Nutrition 0.000 description 2
229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
239000012312 sodium hydride Substances 0.000 description 2
125000001424 substituent group Chemical group 0.000 description 2
229910052717 sulfur Inorganic materials 0.000 description 2
239000011593 sulfur Substances 0.000 description 2
239000000829 suppository Substances 0.000 description 2
INRXZBURPBECJY-UHFFFAOYSA-N tert-butyl-[(3,5-diethoxy-4-fluorophenyl)methoxy]-dimethylsilane Chemical compound CCOC1=CC(CO[Si](C)(C)C(C)(C)C)=CC(OCC)=C1F INRXZBURPBECJY-UHFFFAOYSA-N 0.000 description 2
BCNZYOJHNLTNEZ-UHFFFAOYSA-N tert-butyldimethylsilyl chloride Chemical compound CC(C)(C)[Si](C)(C)Cl BCNZYOJHNLTNEZ-UHFFFAOYSA-N 0.000 description 2
239000004408 titanium dioxide Substances 0.000 description 2
JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 2
WRECIMRULFAWHA-UHFFFAOYSA-N trimethyl borate Chemical compound COB(OC)OC WRECIMRULFAWHA-UHFFFAOYSA-N 0.000 description 2
GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
208000035408 type 1 diabetes mellitus 1 Diseases 0.000 description 2
210000002700 urine Anatomy 0.000 description 2
230000002792 vascular Effects 0.000 description 2
239000011592 zinc chloride Substances 0.000 description 2
235000005074 zinc chloride Nutrition 0.000 description 2
JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
SRKDUHUULIWXFT-UHFFFAOYSA-N (2,2-dimethyl-1,3-dioxolan-4-yl)methyl 4-methylbenzenesulfonate Chemical compound C1=CC(C)=CC=C1S(=O)(=O)OCC1OC(C)(C)OC1 SRKDUHUULIWXFT-UHFFFAOYSA-N 0.000 description 1
YDGJTFCKLFLWFM-UHFFFAOYSA-N (2,6-dichloropyridin-4-yl)methanol Chemical compound OCC1=CC(Cl)=NC(Cl)=C1 YDGJTFCKLFLWFM-UHFFFAOYSA-N 0.000 description 1
QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
ITOFPJRDSCGOSA-KZLRUDJFSA-N (2s)-2-[[(4r)-4-[(3r,5r,8r,9s,10s,13r,14s,17r)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]-3-(1h-indol-3-yl)propanoic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H](CC[C@]13C)[C@@H]2[C@@H]3CC[C@@H]1[C@H](C)CCC(=O)N[C@H](C(O)=O)CC1=CNC2=CC=CC=C12 ITOFPJRDSCGOSA-KZLRUDJFSA-N 0.000 description 1
LGHCFTLNJIGDHU-UHFFFAOYSA-N (3,5-diethoxy-4-pyrrol-1-ylphenyl)methanol Chemical compound CCOC1=CC(CO)=CC(OCC)=C1N1C=CC=C1 LGHCFTLNJIGDHU-UHFFFAOYSA-N 0.000 description 1
IWZSHWBGHQBIML-ZGGLMWTQSA-N (3S,8S,10R,13S,14S,17S)-17-isoquinolin-7-yl-N,N,10,13-tetramethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-amine Chemical compound CN(C)[C@H]1CC[C@]2(C)C3CC[C@@]4(C)[C@@H](CC[C@@H]4c4ccc5ccncc5c4)[C@@H]3CC=C2C1 IWZSHWBGHQBIML-ZGGLMWTQSA-N 0.000 description 1
JHHZLHWJQPUNKB-SCSAIBSYSA-N (3r)-pyrrolidin-3-ol Chemical compound O[C@@H]1CCNC1 JHHZLHWJQPUNKB-SCSAIBSYSA-N 0.000 description 1
YXAICPZUFDAGSV-UHFFFAOYSA-N (4-amino-3,5-diethoxyphenyl)methanol Chemical compound CCOC1=CC(CO)=CC(OCC)=C1N YXAICPZUFDAGSV-UHFFFAOYSA-N 0.000 description 1
HXQNXEZHJYMZRY-UHFFFAOYSA-N (4-chloro-3-ethoxyphenyl)methanol Chemical compound CCOC1=CC(CO)=CC=C1Cl HXQNXEZHJYMZRY-UHFFFAOYSA-N 0.000 description 1
GEZMEIHVFSWOCA-UHFFFAOYSA-N (4-fluorophenyl)methanol Chemical compound OCC1=CC=C(F)C=C1 GEZMEIHVFSWOCA-UHFFFAOYSA-N 0.000 description 1
125000006701 (C1-C7) alkyl group Chemical group 0.000 description 1
WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
GCMNJUJAKQGROZ-UHFFFAOYSA-N 1,2-Dihydroquinolin-2-imine Chemical compound C1=CC=CC2=NC(N)=CC=C21 GCMNJUJAKQGROZ-UHFFFAOYSA-N 0.000 description 1
NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
KPKNTUUIEVXMOH-UHFFFAOYSA-N 1,4-dioxa-8-azaspiro[4.5]decane Chemical compound O1CCOC11CCNCC1 KPKNTUUIEVXMOH-UHFFFAOYSA-N 0.000 description 1
FRKALFGAVVBKKL-UHFFFAOYSA-N 1-[(3-ethoxy-4-methoxyphenyl)methyl]piperidine Chemical compound C1=C(OC)C(OCC)=CC(CN2CCCCC2)=C1 FRKALFGAVVBKKL-UHFFFAOYSA-N 0.000 description 1
ZLVILPASNGXLNE-UHFFFAOYSA-N 1-[4-[6-[[1-[(4-chloro-3,5-diethoxyphenyl)methyl]piperidin-4-yl]amino]pyridine-3-carbonyl]piperazin-1-yl]ethanone Chemical compound CCOC1=C(Cl)C(OCC)=CC(CN2CCC(CC2)NC=2N=CC(=CC=2)C(=O)N2CCN(CC2)C(C)=O)=C1 ZLVILPASNGXLNE-UHFFFAOYSA-N 0.000 description 1
MLEGMEBCXGDFQT-UHFFFAOYSA-N 1-benzylpiperidin-2-one Chemical compound O=C1CCCCN1CC1=CC=CC=C1 MLEGMEBCXGDFQT-UHFFFAOYSA-N 0.000 description 1
HLVFKOKELQSXIQ-UHFFFAOYSA-N 1-bromo-2-methylpropane Chemical compound CC(C)CBr HLVFKOKELQSXIQ-UHFFFAOYSA-N 0.000 description 1
125000004973 1-butenyl group Chemical group C(=CCC)* 0.000 description 1
MSQCQINLJMEVNJ-UHFFFAOYSA-N 1-chloroisoquinoline Chemical compound C1=CC=C2C(Cl)=NC=CC2=C1 MSQCQINLJMEVNJ-UHFFFAOYSA-N 0.000 description 1
125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
238000005160 1H NMR spectroscopy Methods 0.000 description 1
QNBJYUUUYZVIJP-UHFFFAOYSA-N 2,4-dichloroquinoline Chemical compound C1=CC=CC2=NC(Cl)=CC(Cl)=C21 QNBJYUUUYZVIJP-UHFFFAOYSA-N 0.000 description 1
GFISDBXSWQMOND-UHFFFAOYSA-N 2,5-dimethoxyoxolane Chemical compound COC1CCC(OC)O1 GFISDBXSWQMOND-UHFFFAOYSA-N 0.000 description 1
RECCFKQDZVZYJE-UHFFFAOYSA-N 2,6-diethoxy-4-formylbenzoic acid Chemical compound CCOC1=CC(C=O)=CC(OCC)=C1C(O)=O RECCFKQDZVZYJE-UHFFFAOYSA-N 0.000 description 1
VQWGDQGQPQLAGQ-UHFFFAOYSA-N 2,7-dichloro-4-(chloromethyl)quinoline Chemical compound ClC1=CC=C2C(CCl)=CC(Cl)=NC2=C1 VQWGDQGQPQLAGQ-UHFFFAOYSA-N 0.000 description 1
VAXOCTXTVIVOQE-UHFFFAOYSA-N 2,8-dichloroquinoline Chemical compound C1=CC=C(Cl)C2=NC(Cl)=CC=C21 VAXOCTXTVIVOQE-UHFFFAOYSA-N 0.000 description 1
YCANYPPCSFCTEN-UHFFFAOYSA-N 2-(6-chloro-3-pyridinyl)-1H-benzimidazole Chemical compound C1=NC(Cl)=CC=C1C1=NC2=CC=CC=C2N1 YCANYPPCSFCTEN-UHFFFAOYSA-N 0.000 description 1
JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
LMIQVMKWOZTUFV-UHFFFAOYSA-N 2-[[1-[(3,5-diethoxy-4-fluorophenyl)methyl]piperidin-4-yl]amino]pyridine-4-carboxamide Chemical compound CCOC1=C(F)C(OCC)=CC(CN2CCC(CC2)NC=2N=CC=C(C=2)C(N)=O)=C1 LMIQVMKWOZTUFV-UHFFFAOYSA-N 0.000 description 1
YQALKKHRTOJSRV-UHFFFAOYSA-N 2-[[1-[(4-chloro-3-ethoxyphenyl)methyl]piperidin-4-yl]amino]pyridine-4-carboxamide Chemical compound C1=C(Cl)C(OCC)=CC(CN2CCC(CC2)NC=2N=CC=C(C=2)C(N)=O)=C1 YQALKKHRTOJSRV-UHFFFAOYSA-N 0.000 description 1
ZWTYQZDBCFVGKR-UHFFFAOYSA-N 2-[[1-[[3,5-di(propan-2-yloxy)phenyl]methyl]piperidin-4-yl]amino]pyridine-4-carboxamide Chemical compound CC(C)OC1=CC(OC(C)C)=CC(CN2CCC(CC2)NC=2N=CC=C(C=2)C(N)=O)=C1 ZWTYQZDBCFVGKR-UHFFFAOYSA-N 0.000 description 1
ZRXQHWYUAIXKRL-UHFFFAOYSA-N 2-bromo-5-methylsulfonylpyridine Chemical compound CS(=O)(=O)C1=CC=C(Br)N=C1 ZRXQHWYUAIXKRL-UHFFFAOYSA-N 0.000 description 1
REXUYBKPWIPONM-UHFFFAOYSA-N 2-bromoacetonitrile Chemical compound BrCC#N REXUYBKPWIPONM-UHFFFAOYSA-N 0.000 description 1
NAMYKGVDVNBCFQ-UHFFFAOYSA-N 2-bromopropane Chemical compound CC(C)Br NAMYKGVDVNBCFQ-UHFFFAOYSA-N 0.000 description 1
125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 description 1
RXATZPCCMYMPME-UHFFFAOYSA-N 2-chloro-3-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=CN=C1Cl RXATZPCCMYMPME-UHFFFAOYSA-N 0.000 description 1
QLUMNDLJGBUHPB-UHFFFAOYSA-N 2-chloro-5-phenylmethoxypyridine Chemical compound C1=NC(Cl)=CC=C1OCC1=CC=CC=C1 QLUMNDLJGBUHPB-UHFFFAOYSA-N 0.000 description 1
JHFKYMZGAPNNPX-UHFFFAOYSA-N 2-chloro-6-[[1-[(3,5-diethoxy-4-fluorophenyl)methyl]piperidin-4-yl]amino]pyridine-4-carboxylic acid Chemical compound ClC=1C=C(C(=O)O)C=C(N=1)NC1CCN(CC1)CC1=CC(=C(C(=C1)OCC)F)OCC JHFKYMZGAPNNPX-UHFFFAOYSA-N 0.000 description 1
SMQLATCKSIVLDC-UHFFFAOYSA-N 2-chloro-6-[[1-[(3-ethoxy-4-methoxyphenyl)methyl]piperidin-4-yl]amino]-5-fluoropyridine-3-carbonitrile Chemical compound C1=C(OC)C(OCC)=CC(CN2CCC(CC2)NC=2C(=CC(=C(Cl)N=2)C#N)F)=C1 SMQLATCKSIVLDC-UHFFFAOYSA-N 0.000 description 1
FFKOIQVMFBXRJY-UHFFFAOYSA-N 2-chloro-6-[[1-[(3-ethoxy-4-methoxyphenyl)methyl]piperidin-4-yl]amino]pyridine-4-carboxylic acid Chemical compound ClC=1C=C(C(=O)O)C=C(N=1)NC1CCN(CC1)CC1=CC(=C(C=C1)OC)OCC FFKOIQVMFBXRJY-UHFFFAOYSA-N 0.000 description 1
IKKNXDBSPNSUOA-UHFFFAOYSA-N 2-chloro-6-methyl-5-phenylpyridine-3-carbonitrile Chemical compound CC1=NC(Cl)=C(C#N)C=C1C1=CC=CC=C1 IKKNXDBSPNSUOA-UHFFFAOYSA-N 0.000 description 1
YSBNBAYNISAUIT-UHFFFAOYSA-N 2-chloro-6-methylpyridine-3-carbonitrile Chemical compound CC1=CC=C(C#N)C(Cl)=N1 YSBNBAYNISAUIT-UHFFFAOYSA-N 0.000 description 1
GELVZYOEQVJIRR-UHFFFAOYSA-N 2-chloropyrazine Chemical class ClC1=CN=CC=N1 GELVZYOEQVJIRR-UHFFFAOYSA-N 0.000 description 1
150000005759 2-chloropyridine Chemical class 0.000 description 1
QRXBTPFMCTXCRD-UHFFFAOYSA-N 2-chloropyridine-4-carbonitrile Chemical compound ClC1=CC(C#N)=CC=N1 QRXBTPFMCTXCRD-UHFFFAOYSA-N 0.000 description 1
150000005642 2-chloroquinolines Chemical class 0.000 description 1
DUVJMSPTZMCSTQ-UHFFFAOYSA-N 2-ethoxybenzaldehyde Chemical compound CCOC1=CC=CC=C1C=O DUVJMSPTZMCSTQ-UHFFFAOYSA-N 0.000 description 1
125000004791 2-fluoroethoxy group Chemical group FCCO* 0.000 description 1
150000005749 2-halopyridines Chemical class 0.000 description 1
150000005635 2-haloquinolines Chemical class 0.000 description 1
125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 1
125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 1
VQNDBXJTIJKJPV-UHFFFAOYSA-N 2h-triazolo[4,5-b]pyridine Chemical compound C1=CC=NC2=NNN=C21 VQNDBXJTIJKJPV-UHFFFAOYSA-N 0.000 description 1
NABCKAVKTGQCLD-UHFFFAOYSA-N 3,5-diethoxy-4-(4-fluorophenyl)benzaldehyde Chemical compound CCOC1=CC(C=O)=CC(OCC)=C1C1=CC=C(F)C=C1 NABCKAVKTGQCLD-UHFFFAOYSA-N 0.000 description 1
LNVWRBNPXCUYJI-UHFFFAOYSA-N 3,5-dimethyl-1h-pyrazol-4-amine Chemical compound CC1=NNC(C)=C1N LNVWRBNPXCUYJI-UHFFFAOYSA-N 0.000 description 1
MQCYIYBPWOKVRR-UHFFFAOYSA-N 3-(2-fluoroethoxy)-4-methoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C=C1OCCF MQCYIYBPWOKVRR-UHFFFAOYSA-N 0.000 description 1
LJGHYPLBDBRCRZ-UHFFFAOYSA-N 3-(3-aminophenyl)sulfonylaniline Chemical group NC1=CC=CC(S(=O)(=O)C=2C=C(N)C=CC=2)=C1 LJGHYPLBDBRCRZ-UHFFFAOYSA-N 0.000 description 1
FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 1
YGYGASJNJTYNOL-CQSZACIVSA-N 3-[(4r)-2,2-dimethyl-1,1-dioxothian-4-yl]-5-(4-fluorophenyl)-1h-indole-7-carboxamide Chemical compound C1CS(=O)(=O)C(C)(C)C[C@@H]1C1=CNC2=C(C(N)=O)C=C(C=3C=CC(F)=CC=3)C=C12 YGYGASJNJTYNOL-CQSZACIVSA-N 0.000 description 1
KLZBODQCMUSXGJ-UHFFFAOYSA-N 3-[6-(piperidin-4-ylamino)pyridin-3-yl]oxypropane-1,2-diol Chemical compound N1=CC(OCC(O)CO)=CC=C1NC1CCNCC1 KLZBODQCMUSXGJ-UHFFFAOYSA-N 0.000 description 1
RRNWAHCJTJOZAX-UHFFFAOYSA-N 3-[tert-butyl(dimethyl)silyl]oxy-5-[[tert-butyl(dimethyl)silyl]oxymethyl]-2-fluorophenol Chemical compound CC(C)(C)[Si](C)(C)OCC1=CC(O)=C(F)C(O[Si](C)(C)C(C)(C)C)=C1 RRNWAHCJTJOZAX-UHFFFAOYSA-N 0.000 description 1
BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
HDYNIWBNWMFBDO-UHFFFAOYSA-N 3-bromo-2-chloropyridine Chemical compound ClC1=NC=CC=C1Br HDYNIWBNWMFBDO-UHFFFAOYSA-N 0.000 description 1
VTOQFOCYBTVOJZ-UHFFFAOYSA-N 3-bromopentane Chemical compound CCC(Br)CC VTOQFOCYBTVOJZ-UHFFFAOYSA-N 0.000 description 1
125000004975 3-butenyl group Chemical group C(CC=C)* 0.000 description 1
CSSRHTDXZIBTMI-UHFFFAOYSA-N 3-butoxy-4-methoxybenzaldehyde Chemical compound CCCCOC1=CC(C=O)=CC=C1OC CSSRHTDXZIBTMI-UHFFFAOYSA-N 0.000 description 1
MNCKJTCGDYKJNO-UHFFFAOYSA-N 3-chloro-n-[1-[(3,5-diethoxy-4-fluorophenyl)methyl]piperidin-4-yl]isoquinolin-1-amine Chemical compound CCOC1=C(F)C(OCC)=CC(CN2CCC(CC2)NC=2C3=CC=CC=C3C=C(Cl)N=2)=C1 MNCKJTCGDYKJNO-UHFFFAOYSA-N 0.000 description 1
VOGHLRMXUGAUSF-UHFFFAOYSA-N 3-chloro-n-[1-[(8-ethoxy-2,2-dimethylchromen-6-yl)methyl]piperidin-4-yl]isoquinolin-1-amine Chemical compound C1=CC(C)(C)OC2=C1C=C(CN1CCC(CC1)NC=1C3=CC=CC=C3C=C(Cl)N=1)C=C2OCC VOGHLRMXUGAUSF-UHFFFAOYSA-N 0.000 description 1
DGNVGSWIKOPKFW-UHFFFAOYSA-N 3-chloro-n-piperidin-4-ylisoquinolin-1-amine Chemical compound N=1C(Cl)=CC2=CC=CC=C2C=1NC1CCNCC1 DGNVGSWIKOPKFW-UHFFFAOYSA-N 0.000 description 1
OLPKSAOIAXJEBE-UHFFFAOYSA-N 3-ethoxy-4-iodo-5-(methoxymethoxy)benzaldehyde Chemical compound CCOC1=CC(C=O)=CC(OCOC)=C1I OLPKSAOIAXJEBE-UHFFFAOYSA-N 0.000 description 1
AERHYKZDBBCHNH-UHFFFAOYSA-N 3-ethoxy-4-pentan-3-yloxybenzaldehyde Chemical compound CCOC1=CC(C=O)=CC=C1OC(CC)CC AERHYKZDBBCHNH-UHFFFAOYSA-N 0.000 description 1
DHVJHJQBQKKPNB-UHFFFAOYSA-N 3-hydroxy-4-methylbenzaldehyde Chemical compound CC1=CC=C(C=O)C=C1O DHVJHJQBQKKPNB-UHFFFAOYSA-N 0.000 description 1
QLILRKBRWXALIE-UHFFFAOYSA-N 3-nitropyridine Chemical compound [O-][N+](=O)C1=CC=CN=C1 QLILRKBRWXALIE-UHFFFAOYSA-N 0.000 description 1
FQGGVYXYBLDJFW-UHFFFAOYSA-N 3-propan-2-yloxy-5-[[4-(quinolin-2-ylamino)piperidin-1-yl]methyl]phenol Chemical compound CC(C)OC1=CC(O)=CC(CN2CCC(CC2)NC=2N=C3C=CC=CC3=CC=2)=C1 FQGGVYXYBLDJFW-UHFFFAOYSA-N 0.000 description 1
KHHFBSDAQXZMFQ-UHFFFAOYSA-N 4-(bromomethyl)-2,7-dichloroquinoline Chemical compound BrCC1=CC(Cl)=NC2=CC(Cl)=CC=C21 KHHFBSDAQXZMFQ-UHFFFAOYSA-N 0.000 description 1
JQGKGOUVRJYGNO-UHFFFAOYSA-N 4-(bromomethyl)-7-chloro-1h-quinolin-2-one Chemical compound C1=CC(Cl)=CC2=NC(O)=CC(CBr)=C21 JQGKGOUVRJYGNO-UHFFFAOYSA-N 0.000 description 1
VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 1
CBXQHLOQSHKJDE-UHFFFAOYSA-N 4-[(4-chloroquinolin-2-yl)amino]piperidine-1-carboxylic acid Chemical compound ClC1=CC(=NC2=CC=CC=C12)NC1CCN(CC1)C(=O)O CBXQHLOQSHKJDE-UHFFFAOYSA-N 0.000 description 1
IRNPCIMNYMWUGV-UHFFFAOYSA-N 4-[(5-cyanopyridin-2-yl)amino]piperidine-1-carboxylic acid Chemical compound C(#N)C=1C=CC(=NC1)NC1CCN(CC1)C(=O)O IRNPCIMNYMWUGV-UHFFFAOYSA-N 0.000 description 1
ZGBWNKAWEXOYJY-UHFFFAOYSA-N 4-[(5-hydroxypyridin-2-yl)amino]piperidine-1-carboxylic acid Chemical compound OC=1C=CC(=NC1)NC1CCN(CC1)C(=O)O ZGBWNKAWEXOYJY-UHFFFAOYSA-N 0.000 description 1
MNEYJJWBMBFVIL-UHFFFAOYSA-N 4-[(8-chloroquinolin-2-yl)amino]piperidine-1-carboxylic acid Chemical compound ClC=1C=CC=C2C=CC(=NC12)NC1CCN(CC1)C(=O)O MNEYJJWBMBFVIL-UHFFFAOYSA-N 0.000 description 1
QFSZWKWOLQRTOV-UHFFFAOYSA-N 4-[[4-[(8-chloroquinolin-2-yl)amino]piperidin-1-yl]methyl]-2-ethoxyphenol Chemical compound C1=C(O)C(OCC)=CC(CN2CCC(CC2)NC=2N=C3C(Cl)=CC=CC3=CC=2)=C1 QFSZWKWOLQRTOV-UHFFFAOYSA-N 0.000 description 1
SCCPWDWKVPHBFU-UHFFFAOYSA-N 4-amino-3,5-diethoxybenzaldehyde Chemical compound CCOC1=CC(C=O)=CC(OCC)=C1N SCCPWDWKVPHBFU-UHFFFAOYSA-N 0.000 description 1
JLAUQFYXUIJUQP-UHFFFAOYSA-N 4-bromo-3,5-diethoxybenzaldehyde Chemical compound CCOC1=CC(C=O)=CC(OCC)=C1Br JLAUQFYXUIJUQP-UHFFFAOYSA-N 0.000 description 1
NUTRHYYFCDEALP-UHFFFAOYSA-N 4-bromo-3,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=C(Br)C(O)=C1 NUTRHYYFCDEALP-UHFFFAOYSA-N 0.000 description 1
VNAMTDVYIPEEGY-UHFFFAOYSA-N 4-chloro-n-[1-[(3-ethoxy-4-methylphenyl)methyl]piperidin-4-yl]quinolin-2-amine Chemical compound C1=C(C)C(OCC)=CC(CN2CCC(CC2)NC=2N=C3C=CC=CC3=C(Cl)C=2)=C1 VNAMTDVYIPEEGY-UHFFFAOYSA-N 0.000 description 1
PPIXMAWFYSOZMU-UHFFFAOYSA-N 4-chloro-n-piperidin-4-ylquinolin-2-amine;dihydrochloride Chemical compound Cl.Cl.N=1C2=CC=CC=C2C(Cl)=CC=1NC1CCNCC1 PPIXMAWFYSOZMU-UHFFFAOYSA-N 0.000 description 1
JRHHJNMASOIRDS-UHFFFAOYSA-N 4-ethoxybenzaldehyde Chemical compound CCOC1=CC=C(C=O)C=C1 JRHHJNMASOIRDS-UHFFFAOYSA-N 0.000 description 1
HRXZRAXKKNUKRF-UHFFFAOYSA-N 4-ethylaniline Chemical compound CCC1=CC=C(N)C=C1 HRXZRAXKKNUKRF-UHFFFAOYSA-N 0.000 description 1
QATKOZUHTGAWMG-UHFFFAOYSA-N 4-fluoro-3-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(F)C(O)=C1 QATKOZUHTGAWMG-UHFFFAOYSA-N 0.000 description 1
UOQXIWFBQSVDPP-UHFFFAOYSA-N 4-fluorobenzaldehyde Chemical compound FC1=CC=C(C=O)C=C1 UOQXIWFBQSVDPP-UHFFFAOYSA-N 0.000 description 1
125000004176 4-fluorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1F)C([H])([H])* 0.000 description 1
125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 description 1
LBUNNMJLXWQQBY-UHFFFAOYSA-N 4-fluorophenylboronic acid Chemical compound OB(O)C1=CC=C(F)C=C1 LBUNNMJLXWQQBY-UHFFFAOYSA-N 0.000 description 1
RGHHSNMVTDWUBI-UHFFFAOYSA-N 4-hydroxybenzaldehyde Chemical compound OC1=CC=C(C=O)C=C1 RGHHSNMVTDWUBI-UHFFFAOYSA-N 0.000 description 1
NIEBHDXUIJSHSL-UHFFFAOYSA-N 4-iodobenzaldehyde Chemical compound IC1=CC=C(C=O)C=C1 NIEBHDXUIJSHSL-UHFFFAOYSA-N 0.000 description 1
WUDYMKBALKOCCE-UHFFFAOYSA-N 4-methoxy-3-prop-2-enoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C=C1OCC=C WUDYMKBALKOCCE-UHFFFAOYSA-N 0.000 description 1
125000006181 4-methyl benzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])C([H])([H])* 0.000 description 1
RZHWRMRHWOSKTI-UHFFFAOYSA-N 4-methyl-n-piperidin-4-ylquinolin-2-amine Chemical compound N=1C2=CC=CC=C2C(C)=CC=1NC1CCNCC1 RZHWRMRHWOSKTI-UHFFFAOYSA-N 0.000 description 1
LLBZPESJRQGYMB-UHFFFAOYSA-N 4-one Natural products O1C(C(=O)CC)CC(C)C11C2(C)CCC(C3(C)C(C(C)(CO)C(OC4C(C(O)C(O)C(COC5C(C(O)C(O)CO5)OC5C(C(OC6C(C(O)C(O)C(CO)O6)O)C(O)C(CO)O5)OC5C(C(O)C(O)C(C)O5)O)O4)O)CC3)CC3)=C3C2(C)CC1 LLBZPESJRQGYMB-UHFFFAOYSA-N 0.000 description 1
ISDBWOPVZKNQDW-UHFFFAOYSA-N 4-phenylbenzaldehyde Chemical compound C1=CC(C=O)=CC=C1C1=CC=CC=C1 ISDBWOPVZKNQDW-UHFFFAOYSA-N 0.000 description 1
WDANSDASCKBVKH-UHFFFAOYSA-N 4-propan-2-yloxybenzaldehyde Chemical compound CC(C)OC1=CC=C(C=O)C=C1 WDANSDASCKBVKH-UHFFFAOYSA-N 0.000 description 1
FGXZWMCBNMMYPL-MSQIWANRSA-N 4-propoxybenzaldehyde Chemical compound CCCO[13C]1=[13CH][13CH]=[13C](C=O)[13CH]=[13CH]1 FGXZWMCBNMMYPL-MSQIWANRSA-N 0.000 description 1
YQBDLLBAKXBHMK-UHFFFAOYSA-N 5-[[1-[(4-chloro-3-ethoxyphenyl)methyl]piperidin-4-yl]amino]pyrazine-2-carboxamide Chemical compound C1=C(Cl)C(OCC)=CC(CN2CCC(CC2)NC=2N=CC(=NC=2)C(N)=O)=C1 YQBDLLBAKXBHMK-UHFFFAOYSA-N 0.000 description 1
GZRXLOKUPKRJJQ-UHFFFAOYSA-N 5-bromo-n-[1-[(3-ethoxy-4-methoxyphenyl)methyl]piperidin-4-yl]pyridin-2-amine Chemical compound C1=C(OC)C(OCC)=CC(CN2CCC(CC2)NC=2N=CC(Br)=CC=2)=C1 GZRXLOKUPKRJJQ-UHFFFAOYSA-N 0.000 description 1
XVMSFILGAMDHEY-UHFFFAOYSA-N 6-(4-aminophenyl)sulfonylpyridin-3-amine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=N1 XVMSFILGAMDHEY-UHFFFAOYSA-N 0.000 description 1
UAWMVMPAYRWUFX-UHFFFAOYSA-N 6-Chloronicotinic acid Chemical compound OC(=O)C1=CC=C(Cl)N=C1 UAWMVMPAYRWUFX-UHFFFAOYSA-N 0.000 description 1
WKRIONHIYLJXKI-UHFFFAOYSA-N 6-[[1-[(3,5-diethoxy-4-fluorophenyl)methyl]piperidin-4-yl]amino]pyridine-3-carbonitrile Chemical compound CCOC1=C(F)C(OCC)=CC(CN2CCC(CC2)NC=2N=CC(=CC=2)C#N)=C1 WKRIONHIYLJXKI-UHFFFAOYSA-N 0.000 description 1
PPLVXDMNXKBVOC-UHFFFAOYSA-N 6-[[1-[(3,5-diethoxy-4-pyrrol-1-ylphenyl)methyl]piperidin-4-yl]amino]pyridine-3-carbonitrile Chemical compound C=1C(OCC)=C(N2C=CC=C2)C(OCC)=CC=1CN(CC1)CCC1NC1=CC=C(C#N)C=N1 PPLVXDMNXKBVOC-UHFFFAOYSA-N 0.000 description 1
CJEFNIXKPUGUMO-UHFFFAOYSA-N 6-[[1-[(3,5-diethoxy-4-pyrrol-1-ylphenyl)methyl]piperidin-4-yl]amino]pyridine-3-carboxamide Chemical compound C=1C(OCC)=C(N2C=CC=C2)C(OCC)=CC=1CN(CC1)CCC1NC1=CC=C(C(N)=O)C=N1 CJEFNIXKPUGUMO-UHFFFAOYSA-N 0.000 description 1
WIMIUMKZPOHYAI-UHFFFAOYSA-N 6-[[1-[(3,5-diethoxyphenyl)methyl]piperidin-4-yl]amino]pyridine-3-carbonitrile Chemical compound CCOC1=CC(OCC)=CC(CN2CCC(CC2)NC=2N=CC(=CC=2)C#N)=C1 WIMIUMKZPOHYAI-UHFFFAOYSA-N 0.000 description 1
AXFCIYFZGHHDLI-UHFFFAOYSA-N 6-[[1-[(3,5-diethoxyphenyl)methyl]piperidin-4-yl]amino]pyridine-3-carboxamide Chemical compound CCOC1=CC(OCC)=CC(CN2CCC(CC2)NC=2N=CC(=CC=2)C(N)=O)=C1 AXFCIYFZGHHDLI-UHFFFAOYSA-N 0.000 description 1
LCWLKBGZVHZBGM-UHFFFAOYSA-N 6-[[1-[(3-ethoxy-4-fluorophenyl)methyl]piperidin-4-yl]amino]pyridine-3-carboxylic acid Chemical compound C1=C(F)C(OCC)=CC(CN2CCC(CC2)NC=2N=CC(=CC=2)C(O)=O)=C1 LCWLKBGZVHZBGM-UHFFFAOYSA-N 0.000 description 1
ZZODFMIGDFPZCP-UHFFFAOYSA-N 6-[[1-[(3-ethoxy-4-hydroxyphenyl)methyl]piperidin-4-yl]amino]pyridine-3-carboxamide Chemical compound C1=C(O)C(OCC)=CC(CN2CCC(CC2)NC=2N=CC(=CC=2)C(N)=O)=C1 ZZODFMIGDFPZCP-UHFFFAOYSA-N 0.000 description 1
SLHTZZOIIXKBTH-UHFFFAOYSA-N 6-[[1-[(3-ethoxy-4-methoxyphenyl)methyl]piperidin-4-yl]amino]pyridine-3-carboxamide Chemical compound C1=C(OC)C(OCC)=CC(CN2CCC(CC2)NC=2N=CC(=CC=2)C(N)=O)=C1 SLHTZZOIIXKBTH-UHFFFAOYSA-N 0.000 description 1
ISBOTCCRKUQQOO-UHFFFAOYSA-N 6-[[1-[(4-amino-3,5-diethoxyphenyl)methyl]piperidin-4-yl]amino]pyridine-3-carbonitrile Chemical compound CCOC1=C(N)C(OCC)=CC(CN2CCC(CC2)NC=2N=CC(=CC=2)C#N)=C1 ISBOTCCRKUQQOO-UHFFFAOYSA-N 0.000 description 1
YWPHVUGWSDHFIP-UHFFFAOYSA-N 6-[[1-[(4-bromo-3,5-diethoxyphenyl)methyl]piperidin-4-yl]amino]pyridine-3-carbonitrile Chemical compound CCOC1=C(Br)C(OCC)=CC(CN2CCC(CC2)NC=2N=CC(=CC=2)C#N)=C1 YWPHVUGWSDHFIP-UHFFFAOYSA-N 0.000 description 1
GLDMSVYQUVWJSE-UHFFFAOYSA-N 6-[[1-[(4-chloro-3,5-diethoxyphenyl)methyl]piperidin-4-yl]amino]-n-(2,2,2-trifluoroethyl)pyridine-3-carboxamide Chemical compound CCOC1=C(Cl)C(OCC)=CC(CN2CCC(CC2)NC=2N=CC(=CC=2)C(=O)NCC(F)(F)F)=C1 GLDMSVYQUVWJSE-UHFFFAOYSA-N 0.000 description 1
BFMXEZHOOVWITH-UHFFFAOYSA-N 6-[[1-[(4-chloro-3,5-diethoxyphenyl)methyl]piperidin-4-yl]amino]pyridine-3-carbonitrile Chemical compound CCOC1=C(Cl)C(OCC)=CC(CN2CCC(CC2)NC=2N=CC(=CC=2)C#N)=C1 BFMXEZHOOVWITH-UHFFFAOYSA-N 0.000 description 1
IDLGJMXPEPIMJC-UHFFFAOYSA-N 6-[[1-[(4-chloro-3-ethoxyphenyl)methyl]piperidin-4-yl]amino]pyridine-3-carboxamide Chemical compound C1=C(Cl)C(OCC)=CC(CN2CCC(CC2)NC=2N=CC(=CC=2)C(N)=O)=C1 IDLGJMXPEPIMJC-UHFFFAOYSA-N 0.000 description 1
YYQFMZSSNCUNJJ-UHFFFAOYSA-N 6-[[1-[(4-methoxy-3-propoxyphenyl)methyl]piperidin-4-yl]amino]pyridine-3-carboxamide Chemical compound C1=C(OC)C(OCCC)=CC(CN2CCC(CC2)NC=2N=CC(=CC=2)C(N)=O)=C1 YYQFMZSSNCUNJJ-UHFFFAOYSA-N 0.000 description 1
LCYXZAQZFVCBIH-UHFFFAOYSA-N 6-[[1-[[3,5-di(propan-2-yloxy)phenyl]methyl]piperidin-4-yl]amino]pyridine-3-carbonitrile Chemical compound CC(C)OC1=CC(OC(C)C)=CC(CN2CCC(CC2)NC=2N=CC(=CC=2)C#N)=C1 LCYXZAQZFVCBIH-UHFFFAOYSA-N 0.000 description 1
JZDKRSXVJZSLLU-UHFFFAOYSA-N 6-[[1-[[3,5-di(propan-2-yloxy)phenyl]methyl]piperidin-4-yl]amino]pyridine-3-carboxamide Chemical compound CC(C)OC1=CC(OC(C)C)=CC(CN2CCC(CC2)NC=2N=CC(=CC=2)C(N)=O)=C1 JZDKRSXVJZSLLU-UHFFFAOYSA-N 0.000 description 1
YSLVEEJEJLDDNZ-UHFFFAOYSA-N 6-[[1-[[4-methoxy-3-(2-methylpropoxy)phenyl]methyl]piperidin-4-yl]amino]-4-(trifluoromethyl)pyridine-3-carboxylic acid Chemical compound C1=C(OCC(C)C)C(OC)=CC=C1CN1CCC(NC=2N=CC(=C(C=2)C(F)(F)F)C(O)=O)CC1 YSLVEEJEJLDDNZ-UHFFFAOYSA-N 0.000 description 1
KYACYQMABWHSDS-UHFFFAOYSA-N 6-[[1-[[4-methoxy-3-(2-methylpropoxy)phenyl]methyl]piperidin-4-yl]amino]pyridine-3-carboxamide Chemical compound C1=C(OCC(C)C)C(OC)=CC=C1CN1CCC(NC=2N=CC(=CC=2)C(N)=O)CC1 KYACYQMABWHSDS-UHFFFAOYSA-N 0.000 description 1
WKURLPFYRFOCKX-UHFFFAOYSA-N 6-n-[1-[(3-ethoxy-4-methoxyphenyl)methyl]piperidin-4-yl]-3-nitropyridine-2,6-diamine Chemical compound C1=C(OC)C(OCC)=CC(CN2CCC(CC2)NC=2N=C(N)C(=CC=2)[N+]([O-])=O)=C1 WKURLPFYRFOCKX-UHFFFAOYSA-N 0.000 description 1
RUSMDMDNFUYZTM-UHFFFAOYSA-N 8-chloroquinoline Chemical compound C1=CN=C2C(Cl)=CC=CC2=C1 RUSMDMDNFUYZTM-UHFFFAOYSA-N 0.000 description 1
RODLPDCALOUSDI-UHFFFAOYSA-N 8-ethoxy-2,2-dimethylchromene-6-carbaldehyde Chemical compound C1=CC(C)(C)OC2=C1C=C(C=O)C=C2OCC RODLPDCALOUSDI-UHFFFAOYSA-N 0.000 description 1
IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 1
QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
239000004475 Arginine Substances 0.000 description 1
229920003084 Avicel® PH-102 Polymers 0.000 description 1
201000004569 Blindness Diseases 0.000 description 1
238000006443 Buchwald-Hartwig cross coupling reaction Methods 0.000 description 1
SXDPQGRNHSLZPC-ZJNRKIDTSA-N CNC(=O)C[C@@H]1C[C@H]([C@@H](CN1)NC(=O)c1cc(c(Cl)o1)-c1c(Cl)cnn1C)c1ccc(F)c(F)c1 Chemical compound CNC(=O)C[C@@H]1C[C@H]([C@@H](CN1)NC(=O)c1cc(c(Cl)o1)-c1c(Cl)cnn1C)c1ccc(F)c(F)c1 SXDPQGRNHSLZPC-ZJNRKIDTSA-N 0.000 description 1
GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
208000024172 Cardiovascular disease Diseases 0.000 description 1
WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
VJMNIPAPYLWDQD-UHFFFAOYSA-N Cl.N1CCC(CC1)NC=1N=CC(=NC1)C(=O)OC Chemical compound Cl.N1CCC(CC1)NC=1N=CC(=NC1)C(=O)OC VJMNIPAPYLWDQD-UHFFFAOYSA-N 0.000 description 1
229910021589 Copper(I) bromide Inorganic materials 0.000 description 1
229910021591 Copper(I) chloride Inorganic materials 0.000 description 1
FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
208000007342 Diabetic Nephropathies Diseases 0.000 description 1
206010012689 Diabetic retinopathy Diseases 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
102000051325 Glucagon Human genes 0.000 description 1
108060003199 Glucagon Proteins 0.000 description 1
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Natural products NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 1
244000068988 Glycine max Species 0.000 description 1
235000010469 Glycine max Nutrition 0.000 description 1
206010018473 Glycosuria Diseases 0.000 description 1
208000013016 Hypoglycemia Diseases 0.000 description 1
206010022489 Insulin Resistance Diseases 0.000 description 1
101710092928 Insulin-like peptide-1 Proteins 0.000 description 1
PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 1
ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
229910010084 LiAlH4 Inorganic materials 0.000 description 1
WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
239000004472 Lysine Substances 0.000 description 1
239000012359 Methanesulfonyl chloride Substances 0.000 description 1
241001139947 Mida Species 0.000 description 1
238000006751 Mitsunobu reaction Methods 0.000 description 1
241000699670 Mus sp. Species 0.000 description 1
ZJMZZNVGNSWOOM-UHFFFAOYSA-N N-(butan-2-yl)-N'-ethyl-6-methoxy-1,3,5-triazine-2,4-diamine Chemical compound CCNC1=NC(NC(C)CC)=NC(OC)=N1 ZJMZZNVGNSWOOM-UHFFFAOYSA-N 0.000 description 1
HTLZVHNRZJPSMI-UHFFFAOYSA-N N-ethylpiperidine Chemical compound CCN1CCCCC1 HTLZVHNRZJPSMI-UHFFFAOYSA-N 0.000 description 1
229910017974 NH40H Inorganic materials 0.000 description 1
239000007832 Na2SO4 Substances 0.000 description 1
GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
208000004880 Polyuria Diseases 0.000 description 1
229920003081 Povidone K 30 Polymers 0.000 description 1
239000012564 Q sepharose fast flow resin Substances 0.000 description 1
IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
206010049416 Short-bowel syndrome Diseases 0.000 description 1
BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
229920002472 Starch Polymers 0.000 description 1
235000021355 Stearic acid Nutrition 0.000 description 1
229930182558 Sterol Chemical class 0.000 description 1
KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
210000001744 T-lymphocyte Anatomy 0.000 description 1
239000012317 TBTU Substances 0.000 description 1
FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
LNUFLCYMSVYYNW-ZPJMAFJPSA-N [(2r,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[[(3s,5s,8r,9s,10s,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl]oxy]-4,5-disulfo Chemical compound O([C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1C[C@@H]2CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CCCC(C)C)[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@H](OS(O)(=O)=O)[C@H]1OS(O)(=O)=O LNUFLCYMSVYYNW-ZPJMAFJPSA-N 0.000 description 1
MOXWXZFFIQCXPJ-UHFFFAOYSA-N [2-chloro-6-[[1-[(4-chloro-3-ethoxyphenyl)methyl]piperidin-4-yl]amino]pyridin-4-yl]methanol Chemical compound C1=C(Cl)C(OCC)=CC(CN2CCC(CC2)NC=2N=C(Cl)C=C(CO)C=2)=C1 MOXWXZFFIQCXPJ-UHFFFAOYSA-N 0.000 description 1
MQZZLFWEMXBTDE-UHFFFAOYSA-N [6-[[1-[[3,5-diethoxy-4-(4-fluorophenyl)phenyl]methyl]piperidin-4-yl]amino]pyridin-3-yl] methanesulfonate Chemical compound C=1C(OCC)=C(C=2C=CC(F)=CC=2)C(OCC)=CC=1CN(CC1)CCC1NC1=CC=C(OS(C)(=O)=O)C=N1 MQZZLFWEMXBTDE-UHFFFAOYSA-N 0.000 description 1
CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical class [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 description 1
CLZISMQKJZCZDN-UHFFFAOYSA-N [benzotriazol-1-yloxy(dimethylamino)methylidene]-dimethylazanium Chemical compound C1=CC=C2N(OC(N(C)C)=[N+](C)C)N=NC2=C1 CLZISMQKJZCZDN-UHFFFAOYSA-N 0.000 description 1
230000005856 abnormality Effects 0.000 description 1
DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
150000001241 acetals Chemical class 0.000 description 1
MBYURAUSRUHYHA-UHFFFAOYSA-N acetic acid;benzaldehyde Chemical compound CC(O)=O.O=CC1=CC=CC=C1 MBYURAUSRUHYHA-UHFFFAOYSA-N 0.000 description 1
125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
229960004308 acetylcysteine Drugs 0.000 description 1
238000007171 acid catalysis Methods 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
239000000654 additive Substances 0.000 description 1
230000000996 additive effect Effects 0.000 description 1
239000003463 adsorbent Substances 0.000 description 1
239000000556 agonist Substances 0.000 description 1
150000001350 alkyl halides Chemical class 0.000 description 1
BHELZAPQIKSEDF-UHFFFAOYSA-N allyl bromide Chemical compound BrCC=C BHELZAPQIKSEDF-UHFFFAOYSA-N 0.000 description 1
229910000147 aluminium phosphate Inorganic materials 0.000 description 1
238000005576 amination reaction Methods 0.000 description 1
229960004050 aminobenzoic acid Drugs 0.000 description 1
235000019270 ammonium chloride Nutrition 0.000 description 1
239000000908 ammonium hydroxide Substances 0.000 description 1
238000002266 amputation Methods 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
HOPRXXXSABQWAV-UHFFFAOYSA-N anhydrous collidine Natural products CC1=CC=NC(C)=C1C HOPRXXXSABQWAV-UHFFFAOYSA-N 0.000 description 1
150000001448 anilines Chemical class 0.000 description 1
230000003042 antagnostic effect Effects 0.000 description 1
230000008485 antagonism Effects 0.000 description 1
229940127003 anti-diabetic drug Drugs 0.000 description 1
229940125708 antidiabetic agent Drugs 0.000 description 1
239000003963 antioxidant agent Substances 0.000 description 1
VEQOALNAAJBPNY-UHFFFAOYSA-N antipyrine Chemical class CN1C(C)=CC(=O)N1C1=CC=CC=C1 VEQOALNAAJBPNY-UHFFFAOYSA-N 0.000 description 1
229940111121 antirheumatic drug quinolines Drugs 0.000 description 1
230000036528 appetite Effects 0.000 description 1
235000019789 appetite Nutrition 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
239000007900 aqueous suspension Substances 0.000 description 1
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
239000012131 assay buffer Substances 0.000 description 1
238000011914 asymmetric synthesis Methods 0.000 description 1
229940062310 avandia Drugs 0.000 description 1
125000002785 azepinyl group Chemical group 0.000 description 1
125000002393 azetidinyl group Chemical group 0.000 description 1
125000004069 aziridinyl group Chemical group 0.000 description 1
UFZOLVFGAOAEHD-UHFFFAOYSA-N benzaldehyde;phenol Chemical compound OC1=CC=CC=C1.O=CC1=CC=CC=C1 UFZOLVFGAOAEHD-UHFFFAOYSA-N 0.000 description 1
125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 1
125000004603 benzisoxazolyl group Chemical group O1N=C(C2=C1C=CC=C2)* 0.000 description 1
125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
150000008359 benzonitriles Chemical class 0.000 description 1
125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 1
125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 1
125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 description 1
230000004071 biological effect Effects 0.000 description 1
230000033228 biological regulation Effects 0.000 description 1
238000009835 boiling Methods 0.000 description 1
239000006172 buffering agent Substances 0.000 description 1
KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 1
239000011575 calcium Substances 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
239000001110 calcium chloride Substances 0.000 description 1
235000011148 calcium chloride Nutrition 0.000 description 1
229910001628 calcium chloride Inorganic materials 0.000 description 1
239000004202 carbamide Substances 0.000 description 1
125000002837 carbocyclic group Chemical group 0.000 description 1
150000001720 carbohydrates Chemical class 0.000 description 1
235000014633 carbohydrates Nutrition 0.000 description 1
150000001721 carbon Chemical group 0.000 description 1
PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 1
239000000969 carrier Substances 0.000 description 1
239000003054 catalyst Substances 0.000 description 1
239000003729 cation exchange resin Substances 0.000 description 1
229920002678 cellulose Chemical class 0.000 description 1
239000001913 cellulose Chemical class 0.000 description 1
235000010980 cellulose Nutrition 0.000 description 1
238000005119 centrifugation Methods 0.000 description 1
210000004978 chinese hamster ovary cell Anatomy 0.000 description 1
125000001309 chloro group Chemical group Cl* 0.000 description 1
125000004651 chloromethoxy group Chemical group ClCO* 0.000 description 1
125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 1
235000013985 cinnamic acid Nutrition 0.000 description 1
229930016911 cinnamic acid Natural products 0.000 description 1
235000015165 citric acid Nutrition 0.000 description 1
UTBIMNXEDGNJFE-UHFFFAOYSA-N collidine Natural products CC1=CC=C(C)C(C)=N1 UTBIMNXEDGNJFE-UHFFFAOYSA-N 0.000 description 1
229940125810 compound 20 Drugs 0.000 description 1
OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 description 1
NKNDPYCGAZPOFS-UHFFFAOYSA-M copper(i) bromide Chemical compound Br[Cu] NKNDPYCGAZPOFS-UHFFFAOYSA-M 0.000 description 1
GBRBMTNGQBKBQE-UHFFFAOYSA-L copper;diiodide Chemical compound I[Cu]I GBRBMTNGQBKBQE-UHFFFAOYSA-L 0.000 description 1
239000006071 cream Substances 0.000 description 1
239000013078 crystal Substances 0.000 description 1
125000004966 cyanoalkyl group Chemical group 0.000 description 1
KZZKOVLJUKWSKX-UHFFFAOYSA-N cyclobutanamine Chemical compound NC1CCC1 KZZKOVLJUKWSKX-UHFFFAOYSA-N 0.000 description 1
125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
230000007850 degeneration Effects 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
208000033679 diabetic kidney disease Diseases 0.000 description 1
150000008049 diazo compounds Chemical class 0.000 description 1
235000005911 diet Nutrition 0.000 description 1
230000037213 diet Effects 0.000 description 1
125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
125000004786 difluoromethoxy group Chemical group [H]C(F)(F)O* 0.000 description 1
125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 description 1
125000004852 dihydrofuranyl group Chemical group O1C(CC=C1)* 0.000 description 1
125000005043 dihydropyranyl group Chemical group O1C(CCC=C1)* 0.000 description 1
229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
238000004821 distillation Methods 0.000 description 1
229940079593 drug Drugs 0.000 description 1
230000009977 dual effect Effects 0.000 description 1
239000000975 dye Substances 0.000 description 1
239000003995 emulsifying agent Substances 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
230000001454 enterotrophic effect Effects 0.000 description 1
CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
125000005745 ethoxymethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])* 0.000 description 1
CAMQXYCFBVNFBA-UHFFFAOYSA-N ethyl 2,6-diethoxy-4-formylbenzoate Chemical compound CCOC(=O)C1=C(OCC)C=C(C=O)C=C1OCC CAMQXYCFBVNFBA-UHFFFAOYSA-N 0.000 description 1
BBPYXTOAVRAKFZ-UHFFFAOYSA-N ethyl 4-chloro-3-ethoxybenzoate Chemical compound CCOC(=O)C1=CC=C(Cl)C(OCC)=C1 BBPYXTOAVRAKFZ-UHFFFAOYSA-N 0.000 description 1
VOBIXFSYNSACIW-UHFFFAOYSA-N ethyl 6-[[1-[(3-ethoxy-4-methoxyphenyl)methyl]piperidin-4-yl]amino]pyridine-3-carboxylate Chemical compound N1=CC(C(=O)OCC)=CC=C1NC1CCN(CC=2C=C(OCC)C(OC)=CC=2)CC1 VOBIXFSYNSACIW-UHFFFAOYSA-N 0.000 description 1
ILDJJTQWIZLGPO-UHFFFAOYSA-N ethyl 6-chloropyridine-3-carboxylate Chemical compound CCOC(=O)C1=CC=C(Cl)N=C1 ILDJJTQWIZLGPO-UHFFFAOYSA-N 0.000 description 1
230000007717 exclusion Effects 0.000 description 1
230000029142 excretion Effects 0.000 description 1
150000002191 fatty alcohols Chemical class 0.000 description 1
239000007941 film coated tablet Substances 0.000 description 1
239000000706 filtrate Substances 0.000 description 1
150000008423 fluorobenzenes Chemical class 0.000 description 1
230000037406 food intake Effects 0.000 description 1
235000012631 food intake Nutrition 0.000 description 1
238000005194 fractionation Methods 0.000 description 1
239000001530 fumaric acid Substances 0.000 description 1
235000011087 fumaric acid Nutrition 0.000 description 1
230000002496 gastric effect Effects 0.000 description 1
210000001035 gastrointestinal tract Anatomy 0.000 description 1
239000008273 gelatin Substances 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
239000012362 glacial acetic acid Substances 0.000 description 1
239000003365 glass fiber Substances 0.000 description 1
MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 1
229960004666 glucagon Drugs 0.000 description 1
230000035780 glucosuria Effects 0.000 description 1
229960002449 glycine Drugs 0.000 description 1
235000013905 glycine and its sodium salt Nutrition 0.000 description 1
229960004275 glycolic acid Drugs 0.000 description 1
239000010439 graphite Substances 0.000 description 1
229910002804 graphite Inorganic materials 0.000 description 1
229940093915 gynecological organic acid Drugs 0.000 description 1
208000027700 hepatic dysfunction Diseases 0.000 description 1
125000003187 heptyl group Chemical class [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
239000003906 humectant Substances 0.000 description 1
230000036571 hydration Effects 0.000 description 1
238000006703 hydration reaction Methods 0.000 description 1
125000001183 hydrocarbyl group Chemical group 0.000 description 1
150000003840 hydrochlorides Chemical class 0.000 description 1
239000008173 hydrogenated soybean oil Substances 0.000 description 1
QYRFJLLXPINATB-UHFFFAOYSA-N hydron;2,4,5,6-tetrafluorobenzene-1,3-diamine;dichloride Chemical compound Cl.Cl.NC1=C(F)C(N)=C(F)C(F)=C1F QYRFJLLXPINATB-UHFFFAOYSA-N 0.000 description 1
125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
229940126904 hypoglycaemic agent Drugs 0.000 description 1
230000002218 hypoglycaemic effect Effects 0.000 description 1
125000002632 imidazolidinyl group Chemical group 0.000 description 1
125000002636 imidazolinyl group Chemical group 0.000 description 1
125000002883 imidazolyl group Chemical group 0.000 description 1
210000002865 immune cell Anatomy 0.000 description 1
210000000987 immune system Anatomy 0.000 description 1
230000007365 immunoregulation Effects 0.000 description 1
238000011534 incubation Methods 0.000 description 1
125000001041 indolyl group Chemical group 0.000 description 1
239000011261 inert gas Substances 0.000 description 1
238000001802 infusion Methods 0.000 description 1
230000005764 inhibitory process Effects 0.000 description 1
230000003914 insulin secretion Effects 0.000 description 1
229960004903 invert sugar Drugs 0.000 description 1
PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
238000004255 ion exchange chromatography Methods 0.000 description 1
239000003456 ion exchange resin Substances 0.000 description 1
229920003303 ion-exchange polymer Polymers 0.000 description 1
SRJOCJYGOFTFLH-UHFFFAOYSA-N isonipecotic acid Chemical compound OC(=O)C1CCNCC1 SRJOCJYGOFTFLH-UHFFFAOYSA-N 0.000 description 1
125000000555 isopropenyl group Chemical group [H]\C([H])=C(\*)C([H])([H])[H] 0.000 description 1
JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 1
125000000654 isopropylidene group Chemical group C(C)(C)=* 0.000 description 1
OSILBMSORKFRTB-UHFFFAOYSA-N isoquinolin-1-amine Chemical compound C1=CC=C2C(N)=NC=CC2=C1 OSILBMSORKFRTB-UHFFFAOYSA-N 0.000 description 1
150000002537 isoquinolines Chemical class 0.000 description 1
125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 description 1
125000004628 isothiazolidinyl group Chemical group S1N(CCC1)* 0.000 description 1
125000001786 isothiazolyl group Chemical group 0.000 description 1
125000003965 isoxazolidinyl group Chemical group 0.000 description 1
150000002576 ketones Chemical class 0.000 description 1
210000003734 kidney Anatomy 0.000 description 1
208000006443 lactic acidosis Diseases 0.000 description 1
229910052744 lithium Inorganic materials 0.000 description 1
239000012280 lithium aluminium hydride Substances 0.000 description 1
210000004185 liver Anatomy 0.000 description 1
OVWYEQOVUDKZNU-UHFFFAOYSA-N m-tolualdehyde Chemical compound CC1=CC=CC(C=O)=C1 OVWYEQOVUDKZNU-UHFFFAOYSA-N 0.000 description 1
159000000003 magnesium salts Chemical class 0.000 description 1
VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
239000011976 maleic acid Substances 0.000 description 1
229960002510 mandelic acid Drugs 0.000 description 1
230000000873 masking effect Effects 0.000 description 1
238000001819 mass spectrum Methods 0.000 description 1
239000000463 material Substances 0.000 description 1
201000000083 maturity-onset diabetes of the young type 1 Diseases 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
239000000155 melt Substances 0.000 description 1
208000030159 metabolic disease Diseases 0.000 description 1
229940098779 methanesulfonic acid Drugs 0.000 description 1
QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
OKKJLVBELUTLKV-VMNATFBRSA-N methanol-d1 Chemical compound [2H]OC OKKJLVBELUTLKV-VMNATFBRSA-N 0.000 description 1
WSFSSNUMVMOOMR-BJUDXGSMSA-N methanone Chemical compound O=[11CH2] WSFSSNUMVMOOMR-BJUDXGSMSA-N 0.000 description 1
125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 1
XSKGHSUHOYEBTK-UHFFFAOYSA-N methyl 2,6-dichloropyridine-4-carboxylate Chemical compound COC(=O)C1=CC(Cl)=NC(Cl)=C1 XSKGHSUHOYEBTK-UHFFFAOYSA-N 0.000 description 1
UZVGTRLHCROUIW-UHFFFAOYSA-N methyl 2-chloro-6-[[1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-4-yl]amino]pyridine-4-carboxylate Chemical compound COC(=O)C1=CC(Cl)=NC(NC2CCN(CC2)C(=O)OC(C)(C)C)=C1 UZVGTRLHCROUIW-UHFFFAOYSA-N 0.000 description 1
GSRKKXMSNUDLOF-UHFFFAOYSA-N methyl 2-chloro-6-[[1-[(4-chloro-3,5-diethoxyphenyl)methyl]piperidin-4-yl]amino]pyridine-4-carboxylate Chemical compound CCOC1=C(Cl)C(OCC)=CC(CN2CCC(CC2)NC=2N=C(Cl)C=C(C=2)C(=O)OC)=C1 GSRKKXMSNUDLOF-UHFFFAOYSA-N 0.000 description 1
UVFMIOMWJOPAGZ-UHFFFAOYSA-N methyl 5-(piperidin-4-ylamino)pyrazine-2-carboxylate;dihydrochloride Chemical compound Cl.Cl.C1=NC(C(=O)OC)=CN=C1NC1CCNCC1 UVFMIOMWJOPAGZ-UHFFFAOYSA-N 0.000 description 1
CVVMLRFXZPKILB-UHFFFAOYSA-N methyl 5-chloropyrazine-2-carboxylate Chemical compound COC(=O)C1=CN=C(Cl)C=N1 CVVMLRFXZPKILB-UHFFFAOYSA-N 0.000 description 1
ICPOVUNCKPUMDB-UHFFFAOYSA-N methyl 6-[[1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-4-yl]amino]-4-(trifluoromethyl)pyridine-3-carboxylate Chemical compound C1=C(C(F)(F)F)C(C(=O)OC)=CN=C1NC1CCN(C(=O)OC(C)(C)C)CC1 ICPOVUNCKPUMDB-UHFFFAOYSA-N 0.000 description 1
125000006178 methyl benzyl group Chemical group 0.000 description 1
125000004492 methyl ester group Chemical group 0.000 description 1
150000004702 methyl esters Chemical class 0.000 description 1
WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
150000007522 mineralic acids Chemical class 0.000 description 1
229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
208000010125 myocardial infarction Diseases 0.000 description 1
DAKZISABEDGGSV-UHFFFAOYSA-N n-(2-aminoethyl)acetamide Chemical compound CC(=O)NCCN DAKZISABEDGGSV-UHFFFAOYSA-N 0.000 description 1
OYFUANKFQBJAJA-UHFFFAOYSA-N n-[1-[(3,5-diethoxy-4-fluorophenyl)methyl]piperidin-4-yl]isoquinolin-1-amine Chemical compound CCOC1=C(F)C(OCC)=CC(CN2CCC(CC2)NC=2C3=CC=CC=C3C=CN=2)=C1 OYFUANKFQBJAJA-UHFFFAOYSA-N 0.000 description 1
WWLZDYZEVUWTQB-UHFFFAOYSA-N n-[1-[(3,5-diethoxy-4-pyrrol-1-ylphenyl)methyl]piperidin-4-yl]-5-(trifluoromethyl)pyridin-2-amine Chemical compound C=1C(OCC)=C(N2C=CC=C2)C(OCC)=CC=1CN(CC1)CCC1NC1=CC=C(C(F)(F)F)C=N1 WWLZDYZEVUWTQB-UHFFFAOYSA-N 0.000 description 1
VDBWDAFVLQYDRY-UHFFFAOYSA-N n-[1-[(3,5-diethoxyphenyl)methyl]piperidin-4-yl]isoquinolin-1-amine Chemical compound CCOC1=CC(OCC)=CC(CN2CCC(CC2)NC=2C3=CC=CC=C3C=CN=2)=C1 VDBWDAFVLQYDRY-UHFFFAOYSA-N 0.000 description 1
WSCZDSBHYGNQLR-UHFFFAOYSA-N n-[1-[(3-butoxy-4-methoxyphenyl)methyl]piperidin-4-yl]-3-chloroisoquinolin-1-amine Chemical compound C1=C(OC)C(OCCCC)=CC(CN2CCC(CC2)NC=2C3=CC=CC=C3C=C(Cl)N=2)=C1 WSCZDSBHYGNQLR-UHFFFAOYSA-N 0.000 description 1
OCCWVHOMUYQIEM-UHFFFAOYSA-N n-[1-[(3-ethoxy-4-fluorophenyl)methyl]piperidin-4-yl]isoquinolin-1-amine Chemical compound C1=C(F)C(OCC)=CC(CN2CCC(CC2)NC=2C3=CC=CC=C3C=CN=2)=C1 OCCWVHOMUYQIEM-UHFFFAOYSA-N 0.000 description 1
USQAQVJUEJUMFS-UHFFFAOYSA-N n-[1-[(3-ethoxy-4-methoxyphenyl)methyl]piperidin-4-yl]-6-fluoroquinolin-2-amine Chemical compound C1=C(OC)C(OCC)=CC(CN2CCC(CC2)NC=2N=C3C=CC(F)=CC3=CC=2)=C1 USQAQVJUEJUMFS-UHFFFAOYSA-N 0.000 description 1
BKLUFNLXFBRCQA-UHFFFAOYSA-N n-[1-[(3-ethoxy-4-methylphenyl)methyl]piperidin-4-yl]isoquinolin-1-amine Chemical compound C1=C(C)C(OCC)=CC(CN2CCC(CC2)NC=2C3=CC=CC=C3C=CN=2)=C1 BKLUFNLXFBRCQA-UHFFFAOYSA-N 0.000 description 1
BRPCJNLRLUXOMJ-UHFFFAOYSA-N n-[1-[(4-amino-3,5-diethoxyphenyl)methyl]piperidin-4-yl]quinolin-2-amine Chemical compound CCOC1=C(N)C(OCC)=CC(CN2CCC(CC2)NC=2N=C3C=CC=CC3=CC=2)=C1 BRPCJNLRLUXOMJ-UHFFFAOYSA-N 0.000 description 1
XJWMJOGFSCTZDM-UHFFFAOYSA-N n-[1-[(4-chloro-3-ethoxyphenyl)methyl]piperidin-4-yl]-4-methylquinolin-2-amine Chemical compound C1=C(Cl)C(OCC)=CC(CN2CCC(CC2)NC=2N=C3C=CC=CC3=C(C)C=2)=C1 XJWMJOGFSCTZDM-UHFFFAOYSA-N 0.000 description 1
IICXOZMHQWZXLI-UHFFFAOYSA-N n-[1-[(8-ethoxy-2,2-dimethylchromen-6-yl)methyl]piperidin-4-yl]quinolin-2-amine Chemical compound C1=CC(C)(C)OC2=C1C=C(CN1CCC(CC1)NC=1N=C3C=CC=CC3=CC=1)C=C2OCC IICXOZMHQWZXLI-UHFFFAOYSA-N 0.000 description 1
FTZSARBNKKHGAM-UHFFFAOYSA-N n-[1-[[3,5-di(propan-2-yloxy)phenyl]methyl]piperidin-4-yl]-4-methylquinolin-2-amine Chemical compound CC(C)OC1=CC(OC(C)C)=CC(CN2CCC(CC2)NC=2N=C3C=CC=CC3=C(C)C=2)=C1 FTZSARBNKKHGAM-UHFFFAOYSA-N 0.000 description 1
ODQAPNPJGJIZDC-UHFFFAOYSA-N n-[1-[[3,5-diethoxy-4-(4-fluorophenyl)phenyl]methyl]piperidin-4-yl]-5-methylsulfonylpyridin-2-amine Chemical compound C=1C(OCC)=C(C=2C=CC(F)=CC=2)C(OCC)=CC=1CN(CC1)CCC1NC1=CC=C(S(C)(=O)=O)C=N1 ODQAPNPJGJIZDC-UHFFFAOYSA-N 0.000 description 1
NZVJAIYUTCSIRH-UHFFFAOYSA-N n-[1-[[3-ethoxy-4-iodo-5-(methoxymethoxy)phenyl]methyl]piperidin-4-yl]-5-(trifluoromethyl)pyridin-2-amine Chemical compound COCOC1=C(I)C(OCC)=CC(CN2CCC(CC2)NC=2N=CC(=CC=2)C(F)(F)F)=C1 NZVJAIYUTCSIRH-UHFFFAOYSA-N 0.000 description 1
JWKQWSXFQOVROH-UHFFFAOYSA-N n-[1-[[4-methoxy-3-(2-methylpropoxy)phenyl]methyl]piperidin-4-yl]isoquinolin-1-amine Chemical compound C1=C(OCC(C)C)C(OC)=CC=C1CN1CCC(NC=2C3=CC=CC=C3C=CN=2)CC1 JWKQWSXFQOVROH-UHFFFAOYSA-N 0.000 description 1
LQUZZKBWPPHCMQ-UHFFFAOYSA-N n-[1-[[4-methoxy-3-(2-methylpropoxy)phenyl]methyl]piperidin-4-yl]quinolin-2-amine Chemical compound C1=C(OCC(C)C)C(OC)=CC=C1CN1CCC(NC=2N=C3C=CC=CC3=CC=2)CC1 LQUZZKBWPPHCMQ-UHFFFAOYSA-N 0.000 description 1
125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
MNHSXSKBHPGQED-UHFFFAOYSA-N n-cyclobutylpyridine-3-carboxamide Chemical compound C=1C=CN=CC=1C(=O)NC1CCC1 MNHSXSKBHPGQED-UHFFFAOYSA-N 0.000 description 1
SOMYHXRJSAEQBL-UHFFFAOYSA-N n-piperidin-4-yl-5-(trifluoromethyl)pyridin-2-amine Chemical compound N1=CC(C(F)(F)F)=CC=C1NC1CCNCC1 SOMYHXRJSAEQBL-UHFFFAOYSA-N 0.000 description 1
UEOKVKFBJUFFPM-UHFFFAOYSA-N n-piperidin-4-ylisoquinolin-1-amine Chemical compound C1CNCCC1NC1=NC=CC2=CC=CC=C12 UEOKVKFBJUFFPM-UHFFFAOYSA-N 0.000 description 1
CRQXHMIWISAWRK-UHFFFAOYSA-N n-piperidin-4-ylisoquinolin-1-amine;dihydrochloride Chemical compound Cl.Cl.C1CNCCC1NC1=NC=CC2=CC=CC=C12 CRQXHMIWISAWRK-UHFFFAOYSA-N 0.000 description 1
GETMYIQPPRWERL-UHFFFAOYSA-N n-piperidin-4-ylquinolin-2-amine Chemical compound C1CNCCC1NC1=CC=C(C=CC=C2)C2=N1 GETMYIQPPRWERL-UHFFFAOYSA-N 0.000 description 1
PVWOIHVRPOBWPI-UHFFFAOYSA-N n-propyl iodide Chemical compound CCCI PVWOIHVRPOBWPI-UHFFFAOYSA-N 0.000 description 1
150000005054 naphthyridines Chemical class 0.000 description 1
239000002858 neurotransmitter agent Substances 0.000 description 1
150000002814 niacins Chemical class 0.000 description 1
150000005480 nicotinamides Chemical class 0.000 description 1
229910017604 nitric acid Inorganic materials 0.000 description 1
150000002825 nitriles Chemical class 0.000 description 1
230000009871 nonspecific binding Effects 0.000 description 1
231100000252 nontoxic Toxicity 0.000 description 1
230000003000 nontoxic effect Effects 0.000 description 1
230000000269 nucleophilic effect Effects 0.000 description 1
QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
239000002674 ointment Substances 0.000 description 1
230000003287 optical effect Effects 0.000 description 1
229940127209 oral hypoglycaemic agent Drugs 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
150000007524 organic acids Chemical class 0.000 description 1
235000005985 organic acids Nutrition 0.000 description 1
150000002894 organic compounds Chemical class 0.000 description 1
238000006053 organic reaction Methods 0.000 description 1
125000002524 organometallic group Chemical group 0.000 description 1
230000003204 osmotic effect Effects 0.000 description 1
125000001715 oxadiazolyl group Chemical group 0.000 description 1
125000000160 oxazolidinyl group Chemical group 0.000 description 1
125000002971 oxazolyl group Chemical group 0.000 description 1
125000003566 oxetanyl group Chemical group 0.000 description 1
125000000466 oxiranyl group Chemical group 0.000 description 1
125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 1
238000007911 parenteral administration Methods 0.000 description 1
230000008506 pathogenesis Effects 0.000 description 1
230000001575 pathological effect Effects 0.000 description 1
230000037361 pathway Effects 0.000 description 1
125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
230000002093 peripheral effect Effects 0.000 description 1
229960005222 phenazone Drugs 0.000 description 1
SGQDWDWJCYEUNC-UHFFFAOYSA-N piperidin-1-ium-4-ylazanium;dichloride Chemical compound Cl.Cl.NC1CCNCC1 SGQDWDWJCYEUNC-UHFFFAOYSA-N 0.000 description 1
KCYQSFOCCXSZQY-UHFFFAOYSA-N piperidin-4-yl carbamate Chemical compound NC(=O)OC1CCNCC1 KCYQSFOCCXSZQY-UHFFFAOYSA-N 0.000 description 1
OHEDMAIVEXQCOZ-UHFFFAOYSA-N piperidine;dihydrochloride Chemical compound Cl.Cl.C1CCNCC1 OHEDMAIVEXQCOZ-UHFFFAOYSA-N 0.000 description 1
239000013612 plasmid Substances 0.000 description 1
239000002798 polar solvent Substances 0.000 description 1
229920001467 poly(styrenesulfonates) Polymers 0.000 description 1
229920001223 polyethylene glycol Chemical class 0.000 description 1
229940068918 polyethylene glycol 400 Drugs 0.000 description 1
229940093429 polyethylene glycol 6000 Drugs 0.000 description 1
229920006316 polyvinylpyrrolidine Polymers 0.000 description 1
235000003784 poor nutrition Nutrition 0.000 description 1
230000000291 postprandial effect Effects 0.000 description 1
239000011591 potassium Substances 0.000 description 1
229910052700 potassium Inorganic materials 0.000 description 1
LJCNRYVRMXRIQR-OLXYHTOASA-L potassium sodium L-tartrate Chemical compound [Na+].[K+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O LJCNRYVRMXRIQR-OLXYHTOASA-L 0.000 description 1
230000003389 potentiating effect Effects 0.000 description 1
230000002028 premature Effects 0.000 description 1
GCYXWQUSHADNBF-AAEALURTSA-N preproglucagon 78-108 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 GCYXWQUSHADNBF-AAEALURTSA-N 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
238000004393 prognosis Methods 0.000 description 1
230000002035 prolonged effect Effects 0.000 description 1
BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
235000019260 propionic acid Nutrition 0.000 description 1
229940095574 propionic acid Drugs 0.000 description 1
150000003216 pyrazines Chemical class 0.000 description 1
125000003373 pyrazinyl group Chemical group 0.000 description 1
125000003072 pyrazolidinyl group Chemical group 0.000 description 1
125000003226 pyrazolyl group Chemical group 0.000 description 1
125000002098 pyridazinyl group Chemical group 0.000 description 1
GKDLGIYCDXPTJS-UHFFFAOYSA-N pyridine-3-carbonitrile dihydrochloride Chemical compound Cl.Cl.N#CC1=CC=CN=C1 GKDLGIYCDXPTJS-UHFFFAOYSA-N 0.000 description 1
UYTIAYOGNOOSNA-UHFFFAOYSA-N pyridine-4-carbonitrile dihydrochloride Chemical compound C(C1=CC=NC=C1)#N.Cl.Cl UYTIAYOGNOOSNA-UHFFFAOYSA-N 0.000 description 1
JUJWROOIHBZHMG-UHFFFAOYSA-O pyridinium Chemical compound C1=CC=[NH+]C=C1 JUJWROOIHBZHMG-UHFFFAOYSA-O 0.000 description 1
125000004076 pyridyl group Chemical group 0.000 description 1
125000000714 pyrimidinyl group Chemical group 0.000 description 1
229940107700 pyruvic acid Drugs 0.000 description 1
IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
150000003248 quinolines Chemical class 0.000 description 1
238000001953 recrystallisation Methods 0.000 description 1
238000005932 reductive alkylation reaction Methods 0.000 description 1
230000001105 regulatory effect Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
125000006413 ring segment Chemical group 0.000 description 1
229960004586 rosiglitazone Drugs 0.000 description 1
SUFUKZSWUHZXAV-BTJKTKAUSA-N rosiglitazone maleate Chemical compound [H+].[H+].[O-]C(=O)\C=C/C([O-])=O.C=1C=CC=NC=1N(C)CCOC(C=C1)=CC=C1CC1SC(=O)NC1=O SUFUKZSWUHZXAV-BTJKTKAUSA-N 0.000 description 1
230000035945 sensitivity Effects 0.000 description 1
229910000077 silane Inorganic materials 0.000 description 1
229940023144 sodium glycolate Drugs 0.000 description 1
239000001476 sodium potassium tartrate Substances 0.000 description 1
235000011006 sodium potassium tartrate Nutrition 0.000 description 1
239000008109 sodium starch glycolate Substances 0.000 description 1
229940079832 sodium starch glycolate Drugs 0.000 description 1
229920003109 sodium starch glycolate Polymers 0.000 description 1
229910052938 sodium sulfate Inorganic materials 0.000 description 1
235000011152 sodium sulphate Nutrition 0.000 description 1
239000012453 solvate Substances 0.000 description 1
238000007614 solvation Methods 0.000 description 1
230000009870 specific binding Effects 0.000 description 1
239000003381 stabilizer Substances 0.000 description 1
239000008107 starch Substances 0.000 description 1
229940032147 starch Drugs 0.000 description 1
235000019698 starch Nutrition 0.000 description 1
239000008117 stearic acid Substances 0.000 description 1
150000003432 sterols Chemical class 0.000 description 1
235000003702 sterols Nutrition 0.000 description 1
238000006467 substitution reaction Methods 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
HHVIBTZHLRERCL-UHFFFAOYSA-N sulfonyldimethane Chemical compound CS(C)(=O)=O HHVIBTZHLRERCL-UHFFFAOYSA-N 0.000 description 1
238000001356 surgical procedure Methods 0.000 description 1
GFYHSKONPJXCDE-UHFFFAOYSA-N sym-collidine Natural products CC1=CN=C(C)C(C)=C1 GFYHSKONPJXCDE-UHFFFAOYSA-N 0.000 description 1
239000006188 syrup Substances 0.000 description 1
235000020357 syrup Nutrition 0.000 description 1
230000009885 systemic effect Effects 0.000 description 1
239000011975 tartaric acid Substances 0.000 description 1
235000002906 tartaric acid Nutrition 0.000 description 1
125000004213 tert-butoxy group Chemical group [H]C([H])([H])C(O*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
IHWCJQBBDHTXQL-UHFFFAOYSA-N tert-butyl 4-(quinolin-2-ylamino)piperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1NC1=CC=C(C=CC=C2)C2=N1 IHWCJQBBDHTXQL-UHFFFAOYSA-N 0.000 description 1
KANNFXXOJRQKTB-UHFFFAOYSA-N tert-butyl 4-[(2-methylpropan-2-yl)oxycarbonyl-[5-[(2-methylpropan-2-yl)oxycarbonyloxy]pyridin-2-yl]amino]piperidine-1-carboxylate Chemical compound N1=CC(OC(=O)OC(C)(C)C)=CC=C1N(C(=O)OC(C)(C)C)C1CCN(C(=O)OC(C)(C)C)CC1 KANNFXXOJRQKTB-UHFFFAOYSA-N 0.000 description 1
FSIQADCSKFGOJA-UHFFFAOYSA-N tert-butyl 4-[(4-cyanopyridin-2-yl)amino]piperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1NC1=CC(C#N)=CC=N1 FSIQADCSKFGOJA-UHFFFAOYSA-N 0.000 description 1
JDIHLGYJRMQOEV-UHFFFAOYSA-N tert-butyl 4-[(4-methylquinolin-2-yl)amino]piperidine-1-carboxylate Chemical compound N=1C2=CC=CC=C2C(C)=CC=1NC1CCN(C(=O)OC(C)(C)C)CC1 JDIHLGYJRMQOEV-UHFFFAOYSA-N 0.000 description 1
WAIYEBRDAHTGCO-UHFFFAOYSA-N tert-butyl 4-[[5-(2h-tetrazol-5-yl)pyridin-2-yl]amino]piperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1NC1=CC=C(C=2NN=NN=2)C=N1 WAIYEBRDAHTGCO-UHFFFAOYSA-N 0.000 description 1
ROUYFJUVMYHXFJ-UHFFFAOYSA-N tert-butyl 4-oxopiperidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCC(=O)CC1 ROUYFJUVMYHXFJ-UHFFFAOYSA-N 0.000 description 1
QKSQWQOAUQFORH-UHFFFAOYSA-N tert-butyl n-[(2-methylpropan-2-yl)oxycarbonylimino]carbamate Chemical compound CC(C)(C)OC(=O)N=NC(=O)OC(C)(C)C QKSQWQOAUQFORH-UHFFFAOYSA-N 0.000 description 1
BZLFBRRZGQMGIZ-UHFFFAOYSA-N tert-butyl n-[1-[(3-ethoxy-4-methoxyphenyl)methyl]piperidin-4-yl]carbamate Chemical compound C1=C(OC)C(OCC)=CC(CN2CCC(CC2)NC(=O)OC(C)(C)C)=C1 BZLFBRRZGQMGIZ-UHFFFAOYSA-N 0.000 description 1
ALLXTWGTOSQCPI-UHFFFAOYSA-N tert-butyl n-[1-[(4-chloro-3-ethoxyphenyl)methyl]piperidin-4-yl]carbamate Chemical compound C1=C(Cl)C(OCC)=CC(CN2CCC(CC2)NC(=O)OC(C)(C)C)=C1 ALLXTWGTOSQCPI-UHFFFAOYSA-N 0.000 description 1
CKXZPVPIDOJLLM-UHFFFAOYSA-N tert-butyl n-piperidin-4-ylcarbamate Chemical compound CC(C)(C)OC(=O)NC1CCNCC1 CKXZPVPIDOJLLM-UHFFFAOYSA-N 0.000 description 1
GXKANKGLUSMDFP-UHFFFAOYSA-N tert-butyl-[(4-fluorophenyl)methoxy]-dimethylsilane Chemical compound CC(C)(C)[Si](C)(C)OCC1=CC=C(F)C=C1 GXKANKGLUSMDFP-UHFFFAOYSA-N 0.000 description 1
SVNUFLBQOXEJJF-UHFFFAOYSA-N tert-butyl-[5-(2-tert-butylsilyloxypropan-2-yl)-2-fluorophenoxy]-dimethylsilane Chemical compound C(C)(C)(C)[Si](OC1=C(C=CC(=C1)C(O[SiH2]C(C)(C)C)(C)C)F)(C)C SVNUFLBQOXEJJF-UHFFFAOYSA-N 0.000 description 1
ABNGEOWOTKDJKG-UHFFFAOYSA-N tert-butyl-[[3-[tert-butyl(dimethyl)silyl]oxy-4-fluorophenyl]methoxy]-dimethylsilane Chemical compound CC(C)(C)[Si](C)(C)OCC1=CC=C(F)C(O[Si](C)(C)C(C)(C)C)=C1 ABNGEOWOTKDJKG-UHFFFAOYSA-N 0.000 description 1
125000003718 tetrahydrofuranyl group Chemical group 0.000 description 1
125000001412 tetrahydropyranyl group Chemical group 0.000 description 1
125000005942 tetrahydropyridyl group Chemical group 0.000 description 1
238000010257 thawing Methods 0.000 description 1
125000001984 thiazolidinyl group Chemical group 0.000 description 1
125000000335 thiazolyl group Chemical group 0.000 description 1
125000001544 thienyl group Chemical group 0.000 description 1
125000004568 thiomorpholinyl group Chemical group 0.000 description 1
GLQWRXYOTXRDNH-UHFFFAOYSA-N thiophen-2-amine Chemical compound NC1=CC=CS1 GLQWRXYOTXRDNH-UHFFFAOYSA-N 0.000 description 1
208000037816 tissue injury Diseases 0.000 description 1
238000011200 topical administration Methods 0.000 description 1
230000000699 topical effect Effects 0.000 description 1
125000005490 tosylate group Chemical group 0.000 description 1
238000013519 translation Methods 0.000 description 1
125000001425 triazolyl group Chemical group 0.000 description 1
TUQOTMZNTHZOKS-UHFFFAOYSA-N tributylphosphine Chemical compound CCCCP(CCCC)CCCC TUQOTMZNTHZOKS-UHFFFAOYSA-N 0.000 description 1
WLPUWLXVBWGYMZ-UHFFFAOYSA-N tricyclohexylphosphine Chemical compound C1CCCCC1P(C1CCCCC1)C1CCCCC1 WLPUWLXVBWGYMZ-UHFFFAOYSA-N 0.000 description 1
125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 description 1
HNERGUZACGVRGO-UHFFFAOYSA-N trifluoromethyl pyridine-3-carboxylate Chemical compound FC(F)(F)OC(=O)C1=CC=CN=C1 HNERGUZACGVRGO-UHFFFAOYSA-N 0.000 description 1
YFTHZRPMJXBUME-UHFFFAOYSA-N tripropylamine Chemical compound CCCN(CCC)CCC YFTHZRPMJXBUME-UHFFFAOYSA-N 0.000 description 1
JEJAMASKDTUEBZ-UHFFFAOYSA-N tris(1,1,3-tribromo-2,2-dimethylpropyl) phosphate Chemical compound BrCC(C)(C)C(Br)(Br)OP(=O)(OC(Br)(Br)C(C)(C)CBr)OC(Br)(Br)C(C)(C)CBr JEJAMASKDTUEBZ-UHFFFAOYSA-N 0.000 description 1
GXPHKUHSUJUWKP-UHFFFAOYSA-N troglitazone Chemical compound C1CC=2C(C)=C(O)C(C)=C(C)C=2OC1(C)COC(C=C1)=CC=C1CC1SC(=O)NC1=O GXPHKUHSUJUWKP-UHFFFAOYSA-N 0.000 description 1
229960001641 troglitazone Drugs 0.000 description 1
GXPHKUHSUJUWKP-NTKDMRAZSA-N troglitazone Natural products C([C@@]1(OC=2C(C)=C(C(=C(C)C=2CC1)O)C)C)OC(C=C1)=CC=C1C[C@H]1SC(=O)NC1=O GXPHKUHSUJUWKP-NTKDMRAZSA-N 0.000 description 1
230000001228 trophic effect Effects 0.000 description 1
238000002096 two-dimensional nuclear Overhauser enhancement spectroscopy Methods 0.000 description 1
238000002604 ultrasonography Methods 0.000 description 1
125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
239000011534 wash buffer Substances 0.000 description 1
238000005406 washing Methods 0.000 description 1
230000004584 weight gain Effects 0.000 description 1
235000019786 weight gain Nutrition 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Diabetes (AREA)
Rheumatology (AREA)
Dermatology (AREA)
Hematology (AREA)
Obesity (AREA)
Pain & Pain Management (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Child & Adolescent Psychology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Hydrogenated Pyridines (AREA)

MX2009001498A 2006-08-15 2007-08-06 Derivados de fenilo, piridina y quinolina. MX2009001498A (es)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP06118923		2006-08-15
PCT/EP2007/058114 WO2008019967A2 (fr)	2006-08-15	2007-08-06	Dérivés phényliques, de la pyridine et de la quinoléine

Publications (1)

Publication Number	Publication Date
MX2009001498A true MX2009001498A (es)	2009-02-18

Family

ID=38779568

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MX2009001498A MX2009001498A (es)	2006-08-15	2007-08-06	Derivados de fenilo, piridina y quinolina.

Country Status (15)

Country	Link
US (2)	US7754744B2 (fr)
EP (1)	EP2054385A2 (fr)
JP (1)	JP2010500391A (fr)
KR (1)	KR101117931B1 (fr)
CN (1)	CN101506165B (fr)
AR (1)	AR062357A1 (fr)
AU (1)	AU2007286344A1 (fr)
BR (1)	BRPI0715967A2 (fr)
CA (1)	CA2658960A1 (fr)
CL (1)	CL2007002347A1 (fr)
IL (1)	IL196599A0 (fr)
MX (1)	MX2009001498A (fr)
PE (1)	PE20080543A1 (fr)
TW (1)	TW200817362A (fr)
WO (1)	WO2008019967A2 (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JO2769B1 (en)	2005-10-26	2014-03-15	جانسين فارماسوتيكا ان. في	Rapid decomposition of physiologically antagonistic agents of the 2-dopamine receptor
JO2642B1 (en)	2006-12-08	2012-06-17	جانسين فارماسوتيكا ان. في	Dopamine 2 receptor antagonists are rapidly hydrolyzed
JO2849B1 (en)	2007-02-13	2015-03-15	جانسين فارماسوتيكا ان. في	Dopamine 2 receptor antagonists are rapidly hydrolyzed
US8933101B2 (en)	2007-04-23	2015-01-13	Janssen Pharmaceutica Nv	Thia(dia)zoles as fast dissociating dopamine 2 receptor antagonists
US20100137368A1 (en) *	2007-04-23	2010-06-03	Janssen Pharmaceutica N.V.	Pyridine derivatives as fast dissociating dopamine 2 receptor antagonists
CN102159554B (zh)	2008-07-03	2014-09-24	詹森药业有限公司	作为5-ht6受体拮抗剂的取代的6-(1-哌嗪基)-哒嗪
JP5457450B2 (ja)	2008-07-31	2014-04-02	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	迅速解離性ドーパミン２受容体拮抗薬としてのピペラジン−１−イル−トリフルオロメチル−置換−ピリジン
BRPI0918045A2 (pt) *	2008-09-18	2015-12-01	Astellas Pharma Inc	compostos de carboxamida heterocíclicos
WO2012024183A1 (fr)	2010-08-18	2012-02-23	Merck Sharp & Dohme Corp.	Composés spiroxazolidinone
EP2567959B1 (fr)	2011-09-12	2014-04-16	Sanofi	Dérivés d'amide d'acide 6-(4-hydroxy-phényl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylique en tant qu'inhibiteurs de kinase
JP6380402B2 (ja) *	2013-09-30	2018-08-29	小野薬品工業株式会社	ソマトスタチン受容体作動活性を有する化合物およびその医薬用途
JO3442B1 (ar) *	2013-10-07	2019-10-20	Takeda Pharmaceuticals Co	مضادات ذات نوع فرعي من مستقبل سوماتوستاتين 5 (sstr5)
EP3063139B1 (fr) *	2013-10-29	2018-11-21	Takeda Pharmaceutical Company Limited	Composé hétérocyclique
TW201712012A (zh)	2015-06-16	2017-04-01	美國禮來大藥廠	２－側氧基－１，３，８－三氮雜螺［４．５］癸－３－基羧酸衍生物
EP3458449A1 (fr)	2016-05-20	2019-03-27	Xenon Pharmaceuticals Inc.	Composés benzènesulfonamides et leur utilisation en tant qu'agents thérapeutiques
CA3042004A1 (fr)	2016-12-09	2018-06-14	Xenon Pharmaceuticals Inc.	Composes de benzenesulfonamide et leur utilisation en tant qu'agents therapeutiques
CA3056131A1 (fr)	2017-03-16	2018-09-20	Crinetics Pharmaceuticals, Inc.	Modulateurs de la somatostatine et leurs utilisations
JP7365347B2 (ja)	2018-02-12	2023-10-19	クリネティックスファーマシューティカルズ，インク．	ソマトスタチンモジュレーターおよびその使用
JP7371029B2 (ja)	2018-06-13	2023-10-30	ゼノン・ファーマシューティカルズ・インコーポレイテッド	ベンゼンスルホンアミド化合物および治療剤としてのその使用
AU2019331005B2 (en)	2018-08-31	2024-03-28	Xenon Pharmaceuticals Inc.	Heteroaryl-substituted sulfonamide compounds and their use as therapeutic agents
WO2020047312A1 (fr)	2018-08-31	2020-03-05	Xenon Pharmaceuticals Inc.	Composés de sulfonamide substitués par hétéroaryle et leur utilisation en tant qu'inhibiteurs de canaux sodiques
AR116424A1 (es)	2018-09-18	2021-05-05	Crinetics Pharmaceuticals Inc	Moduladores de la somatostatina y usos de los mismos
WO2020114949A1 (fr) *	2018-12-03	2020-06-11	Boehringer Ingelheim International Gmbh	Composés hétéroaromatiques utilisés en tant qu'inhibiteurs de vanine
TWI841768B (zh)	2019-08-14	2024-05-11	美商克林提克斯醫藥股份有限公司	非肽生長抑制素(somatostatin)5型受體激動劑及其用途
WO2021113363A1 (fr) *	2019-12-03	2021-06-10	Kallyope, Inc.	Antagonistes de sstr5
WO2021199310A1 (fr)	2020-03-31	2021-10-07	エヌ・イーケムキャット株式会社	Procédé de production d'un composé aromatique
IL305011A (en)	2021-02-17	2023-10-01	Crinetics Pharmaceuticals Inc	Crystal forms of a somatostatin modulator
CN115215787A (zh) *	2021-04-19	2022-10-21	中国科学院上海药物研究所	生长抑素受体5拮抗剂及其用途
WO2024129614A1 (fr)	2022-12-13	2024-06-20	Crinetics Pharmaceuticals, Inc.	Agents thérapeutiques ciblés sur le récepteur de la somatostatine de sous-type 2 (sst2r) et leurs utilisations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7217722B2 (en) *	2000-02-01	2007-05-15	Kirin Beer Kabushiki Kaisha	Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same
US6921821B2 (en)	2002-06-12	2005-07-26	Abbott Laboratories	Antagonists of melanin concentrating hormone receptor
JP4666256B2 (ja) *	2002-12-10	2011-04-06	小野薬品工業株式会社	含窒素複素環化合物およびその医薬用途

2007
- 2007-08-06 JP JP2009524168A patent/JP2010500391A/ja active Pending
- 2007-08-06 KR KR1020097002961A patent/KR101117931B1/ko not_active IP Right Cessation
- 2007-08-06 CA CA002658960A patent/CA2658960A1/fr not_active Abandoned
- 2007-08-06 AU AU2007286344A patent/AU2007286344A1/en not_active Abandoned
- 2007-08-06 MX MX2009001498A patent/MX2009001498A/es active IP Right Grant
- 2007-08-06 EP EP07788237A patent/EP2054385A2/fr not_active Withdrawn
- 2007-08-06 US US11/834,184 patent/US7754744B2/en not_active Expired - Fee Related
- 2007-08-06 WO PCT/EP2007/058114 patent/WO2008019967A2/fr active Application Filing
- 2007-08-06 CN CN2007800303854A patent/CN101506165B/zh not_active Expired - Fee Related
- 2007-08-06 BR BRPI0715967-6A patent/BRPI0715967A2/pt not_active IP Right Cessation
- 2007-08-13 AR ARP070103583A patent/AR062357A1/es unknown
- 2007-08-13 TW TW096129866A patent/TW200817362A/zh unknown
- 2007-08-13 PE PE2007001079A patent/PE20080543A1/es not_active Application Discontinuation
- 2007-08-13 CL CL200702347A patent/CL2007002347A1/es unknown
2009
- 2009-01-19 IL IL196599A patent/IL196599A0/en unknown
2010
- 2010-05-10 US US12/776,748 patent/US8026255B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
BRPI0715967A2 (pt)	2013-08-06
CN101506165A (zh)	2009-08-12
PE20080543A1 (es)	2008-05-16
JP2010500391A (ja)	2010-01-07
WO2008019967A2 (fr)	2008-02-21
EP2054385A2 (fr)	2009-05-06
CN101506165B (zh)	2012-07-04
US7754744B2 (en)	2010-07-13
KR101117931B1 (ko)	2012-04-12
IL196599A0 (en)	2009-11-18
US20080045544A1 (en)	2008-02-21
WO2008019967A3 (fr)	2008-04-24
KR20090031620A (ko)	2009-03-26
CA2658960A1 (fr)	2008-02-21
US8026255B2 (en)	2011-09-27
US20100222350A1 (en)	2010-09-02
TW200817362A (en)	2008-04-16
AU2007286344A1 (en)	2008-02-21
CL2007002347A1 (es)	2008-03-14
AR062357A1 (es)	2008-11-05

Publication	Publication Date	Title
MX2009001498A (es)	2009-02-18	Derivados de fenilo, piridina y quinolina.
US7772253B2 (en)	2010-08-10	Amide derivatives as somatostatin receptor 5 antagonists
CN104854086B (zh)	2017-06-27	杂环酰胺衍生物和含有其的药物
US20070093521A1 (en)	2007-04-26	Benzooxazole, oxazolopyridine, benzothiazole and thiazolopyridine derivatives
US10138222B2 (en)	2018-11-27	Substituted benzamides as RIPK2 inhibitors
US7939661B2 (en)	2011-05-10	Pyridine, quinoline and pyrimidine derivatives
WO2008145524A2 (fr)	2008-12-04	Dérivés de pipéridine 4,4-disubstituée
KR101114651B1 (ko)	2012-06-12	5-ｈｔ2ａ 및 ｄ3 수용체 이중 조절자 에터 유도체
TW201938533A (zh)	2019-10-01	經脲及苯基取代之哌啶或哌啶酮

Legal Events

Date	Code	Title	Description
2011-09-08	FG	Grant or registration